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[ i ] 
Antibodies reactive with cellular and nuclear components occur spon-
taneously in patients with systemic lupus erythematosus. The basis for 
spontaneous production of anti-native DNA antibodies in systemic lupus 
erythematosus remains a puzzling question especially in view of the diffi-
culty in their induction on immunization with DNA in B-conformation. 
The anti-dsDNA antibodies seem to be closely related to the disease patho-
genesis through the process of immune complex formation, and their levels 
are frequently indicative of the intensity of disease activity. For reasons 
that are not best understood, anti-DNA antibodies have always exhibited 
polyreactivity with DNA molecules of varying source, size and conformation. 
Analysis of plasma DNA from SLE patients have revealed that these 
molecules are 100-1000 base pair long and rich in G+C sequences. Such 
DNA sequences have the unique potential to undergo B- to Z- or Z-like 
transitions under constraint conditions. 
In the present study purified native calf thymus DNA was digested 
with micrococcal nuclease and fractionated on Sepharose 4B. The approxi-
mate fragment size was determined by standard DNA marker. DNA-(poly-
lysyl-Sepharose ^B) affinity matrix was chosen for the isolation of 
homogeneous anti-DNA antibodies from SLE serum. The affinity purified 
human anti-dsDNA antibody was found to possess polyreactivity with native 
and modified DNA antigens. 
Native DNA covalently modified with lysine under UV-A light (320-
UQQ nm) was found to contain one lysine residue per helical turn. By 
the photoaddition of one lysine molecule per helical turn of DNA, the 
native B-conformation was considerably altered which resulted in the 
appearance of neoepitopes leaving much less epitope typical of B~ 
conformation. Affinity purified anti-dsDNA IgG showed maximum affinity 
towards DNA-lysine photoconjugate followed closely by native DNA, The 
retention of crossreactivity of affinity purified anti-dsDNA IgG with DNA 
-lysine photoadduct strengthen the idea of an alternate antigen for the 
induction of antibodies crossreactive with native DNA, Lysine rich histone 
[ii] 
HI in nucl£03cma thus on nnodification by physical, chemical or environ-
mental agents might form DNA-histone adduct making it imm'jnogenic 
and thus generating antibodies crossreactive with native B-conformation. 
Hydroxy! radical generated by hydrogen peroxide and ferrous ions 
caused single strand breaks in native DNA, cecre?>se in melting tempe.-ature 
(Tm) by 6.5 °C and modification of purine and pyrimidine bases. Experi-
mentally induced antibodies against ROS modified DNA exhibited poly-
reactivity, a property commonly associated with SLE anti-DNA antibodies. 
Native DNA, RNA and synthetic polynucleotides in B-conformati.^n were 
found to be effective inhibitor of induced antibody-immunogen interaction. 
The SLE antibody binding with ROS-DNA was better than native DNA, 
Similar results v/ere observed in competition-inhibition assay, lecause 
of the diminished superoxide dismutase activity in SLE patient: the 
excessively generated free radicals could intercict with DNA resulting 
in its modification. Cnce the native structure of DNA is modified it 
may become immunogenic. 
The binding specificity of SLE anti-DNA IgG with varying DNA 
conformation was analyzed in polyacrylamide or agarose gel. The altered 
electrophoretic mobility in gel retardation assay of A- and B-conformation 
complexed with anti-DNA IgG reiterates the antibody binding to these 
conformers. The above conformers showed high binding with SLE antibodies 
in competition-inhibition experiments. 
The E- to Z- transition of poly(dG~dC).poi;(dC-dC) in '^ .O M NaC! 
was evaluated in terms of "absorption ratio", the average of abcorbance 
at 29^ and 296 nm divided by absorbance at 260 nm. This ratio v/as 
observed to be 0.322. The high salt induced Z-form of poly(dC-dC). poly 
(dG-dC) was stablized by bromination which exhibited Z-DNA characteristics 
when brought in physiological buffer. The low salt brominated polyldG-dC;. 
poly(dG-dC) exhibited the characteristics of B-DNA. Native DNA under 
lov/ or high salt concentration showed "absorbance ratio" greater than 
0.3. Under identical conditins the absorbance ratio for small DNA 
fragments varied between 0.2 to 0.38, The data indicate that small DNA 
fragments have different levels of potentiality to undergo B- to Z- or 
Z-like conformational transitions as the fragments will have variation 
[iii] 
in the G+C and A+T contents. Native DNA or small DNA fragements 
(30C bp) brominated uPider lov,/ or high soidum ch lc ide concentrationj 
indicated regions of interspersed sequences which has the potentiai \o 
undergo B- to Z- or Z-iike transitions. The Z- cr Z-like epitopes on 
brominated native DNA and smaij DNA fragments was confirmed by bindirg 
^nd inhibition data o.f nnonocional and polyclonai anti-Z-DNA antibcdits. 
The effect of varying concentrations of D- and L-polylvfine cr DMA 
showed that in native calf thyrp'.'.-r DNA there ar° certain DNA sequences 
which are sensitive to elevated le/els of poiyannines =',nd car. underg: 
B- to Z- or Z-like transitions. Since the eukaryotic DNA i^ heavily asso-
ciated with protein; rich in lysine, such conformationai transitions nrigh'. 
serve as molecular signal for genetic events inside the cell. That the 
bromination has changed the typical B-characteristics o ' DMA was elso 
proved by decreased p*rcentag« inhibition of SLE anti-dsDNA .'gC- cctiv'ty 
by the brominated forms of DNA compared to high percent inhibitior 
of SLE anti-dsDNA IgG activity v/hen the same polymers v/ere in a typical 
B-conformation. This again shc-vs tnat SLE ar.tibodies are pclyspeciiic 
with respect to binding towards varying DNA conformation. 
In conclusion, native and small DNA fragments have interspersed 
base pair sequences which have the potential to undergo B- to Z- or 
Z-like transitions. Irrespective ci salt concentrations, covalent mrdificaticn 
(e.g, bromination) induces 2- or Z-li'ce helix in native and small DNA 
fragments. That th i epitopes were prese.'ting the features of Z-DNA was 
confirmed by anti-Z-D;JA antibodies binding data,, A detailed study of 
SLE anti-DNA antibody interaction with modified DNA antigens (DNA-
iysine photoconjugate and hydroxy! radical modified r;)NA) have been carried 
out to explore the possibility of participation of these neoantigens in 
the etiopathogenesis of SLE. It appears that the polyspecificity of anti-
DNA antibodies is mujh greater than what is anticipated. 
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[ i ] 
Antibodies reactive with cellular and nuclear components occur spon-
taneously in patients with systemic lupus erythematosus. The basis for 
spontaneous production of anti-native DNA antibodies in systemic lupus 
erythematosus remains a puzzling question especially in view of the diffi-
culty in their induction on immunization with DNA in B-conformation. 
The anti-dsDNA antibodies seem to be closely related to the disease patho-
genesis through the process of immune complex formation, and their levels 
are frequently indicative of the intensity of disease activity. For reasons 
that are not best understood, anti-DNA antibodies have always exhibited 
polyreactivity with DNA molecules of varying source, size and conformation. 
Analysis of plasma DNA from SLE patients have revealed that these 
molecules are 100-1000 base pair long and rich in G+C sequences. Such 
DNA sequences have the unique potential to undergo B- to Z- or Z-like 
transitions under constraint conditions. 
In the present study purified native calf thymus DNA was digested 
with micrococcal nuclease and fractionated on Sepharose ^B. The approxi-
mate fragment size was determined by standard DNA marker. DNA-(poly-
lysyl-Sepharose ^B) affinity matrix was chosen for the isolation of 
homogeneous anti-DNA antibodies from SLE serum. The affinity purified 
human anti-dsDNA antibody was found to possess polyreactivity with native 
and modified DNA antigens. 
Native DNA covalently modified with lysine under UV-A light (320-
14OO nm) was found to contain one lysine residue per helical turn. By 
the photoaddition of one lysine molecule per helical turn of DNA, the 
native B-conformation was considerably altered which resulted in the 
appearance of neoepitopes leaving much less epitope typical of B-
conformation. Affinity purified anti-dsDNA IgG showed maximum affinity 
towards DNA-lysine photoconjugate followed closely by native DNA. The 
retention of crossreactivity of affinity purified anti-dsDNA IgG with DNA 
-lysine photoadduct strengthen the idea of an alternate antigen for the 
induction of antibodies crossreactive with native DNA. Lysine rich histone 
[ i i ] 
HI in nucleosome thus on modif ication by physical, chemical or environ-
mental agents might form DNA-histone adduct making i t immunogenic 
and thus generating antibodies crossreactive wi th native B-conformation. 
Hydroxyl radical generated by hydrogen peroxide and ferrous ions 
caused single strand breaks in native DNA, decrease in melt ing temperature 
(Tm) by 6.5 °C and modif ication of purine and pyrimidine bases. Experi-
mentally induced antibodies against R05 modified DNA exhibited poly-
react iv i ty , a property commonly associated wi th SLE ant i -DNA antibodies. 
Native DNA, RNA and synthetic polynucleotides in B-conformation were 
found to be ef fect ive inhibitor of induced antibody-immunogen interact ion. 
The SLE antibody binding wi th R05-DNA was better than native DNA. 
Similar results were observed in competi t ion-inhibi t ion assay. Because 
of the diminished superoxide dismutase act iv i ty in SLE patients, the 
excessively generated free radicals could interact wi th DNA resulting 
in its modif icat ion. Once the native structure of DNA is modified i t 
may become immunogenic. 
The binding specif ici ty of SLE ant i -DNA IgG wi th varying DNA 
conformation was analyzed in poiyacryiamide or agarose gel. The altered 
electrophoretic mobil i ty in gel retardation assay of A- and B-conformation 
complexed wi th ant i -DNA IgG reiterates the antibody binding to these 
conformers. The above conformers showed high binding wi th SLE antibodies 
in competi t ion-inhibit ion experiments. 
The B- to Z- transit ion of poly(dG-dC).poly(dG-dC) in 4.0 M NaCl 
was evaluated in terms of "absorption rat io" , the average of absorbance 
at 29 *^ and 296 nm divided by absorbance at 260 nm. This rat io was 
observed to be 0.322. The high salt induced Z-form of poly(dG-dC). poly 
(dC-dC) was stablized by bromination which exhibited Z-DNA characteristics 
when brought in physiological buffer. The low salt brominated poly(dG-dC). 
poly(dG-dC) exhibited the characteristics of B-DNA. Native DNA under 
low or high salt concentration showed "absorbance rat io" greater than 
0.3. Under identical conditins the absorbance rat io for small DNA 
fragments varied between 0.2 to 0.38. The data indicate that small DNA 
fragments have di f ferent levels of potent ial i ty to undergo B- to Z- or 
Z-like conformational transitions as the fragments wi l l have variation 
[ i i i ] 
in the G+C and A+T contents. Native DNA or snnail DNA fragements 
(300 bp) brominated under Jew or high soidum chloride concentrations 
indicated regions of interspersed sequences which has the potential to 
undergo B- to Z- or Z-i ike transitions. The Z- or Z-l ike epitopes on 
brominated native DNA and small DNA fragments was confirmed by binding 
and inhibit ion data of monoclonal and polyclonal ant i -Z-DNA antibodies. 
The ef fect of varying concentrations of D- and L-polylysine on DNA 
showed that in native calf thymus DNA there are certain DNA sequences 
which are sensitive to elevated levels of polyamines and can undergo 
B- to Z- or Z-like transitions. Since the eukaryotic DNA is heavily asso-
ciated wi th proteins rich in lysine, such conformational transitions might 
serve as molecular signal for genetic events inside the cel l . That the 
bromination has changed the typical B-characteristics of DNA was also 
proved by decreased percentage inhibit ion of SLE anti-dsDNA IgG act iv i ty 
by the brominated forms of DNA compared to high percent inhibit ion 
of SLE anti-dsDNA IgG act iv i ty when the same polymers were in a typical 
B-conformation. This again shows that SLE antibodies are polyspecific 
with respect to binding towards varying DNA conformation. 
In conclusion, native and small DNA fragments have interspersed 
base pair sequences which have the potential to undergo B- to Z- or 
Z-like transitions. Irrespective of salt concentrations, covalent modif icat ion 
(e.g. bromination) induces Z- or Z-l ike helix in native and small DNA 
fragments. That the epitopes were presenting the features of Z-DNA was 
confirmed by ant i -Z-DNA antibodies binding data. A detailed study of 
SLE ant i -DNA antibody interaction wi th modified DNA antigens (DNA-
lysine photoconjugate and hydroxyl radical modified DNA) have been carried 
out to explore the possibility of part icipation of these neoantigens in 
the etiopathogenesis of SLE. It appears that the poJyspecificlty of an t i -
DNA antibodies is much greater than what is anticipated. 
[iv] 
ABBREVIATIONS 
A-,, . = Absorbance at 260 nm 
BSA = Bovine serum albumin 
dsDNA = Double stranded DNA 
DEAE = DiethylamlnoethyJ 
EDTA = Ethylenediaminetetra-acetic acid 
(disodium salt) 
High salt = i^ M sodium chloride 
IgG = Immunoglobulin G 
Low salt = 0.]5 M sodium chloride 
nDNA = Native DNA 
PUVA = Psoralen plus ultraviolet A light 
R05 = Reactive oxygen species 
RT = Room temperature 
ssDNA = Single stranded DNA 
SLE = Systemic lupus erythematosus 
TEMED = N,N,N',N'-tetraethylenediamine 
Tm = Helix-coil transition temperature 
UV = Ultraviolet 
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The DNA has been the subject of biochemical investigations almost 
from the t ime i t was f i rst isolated from pus cell nuclei (Miescher, 
1879). The information burled in DNA in the form of four-unit language 
gets amplif ied to 20 unit language of protein by simple permutation 
and combination of nucleotides. These events of language translation 
produce various types of polypeptides whose function is dictated by the 
type of cell where the event is taking place. The utmost importance 
of DNA lie in its unique property to adopt mult iple conformations 
depending on its bioenvironment. The environment could mean ions, 
small molecules or even proteins. These alternate conformations are 
likely to play crucial role in gene expression by increased or decreased 
synthesis of regulatory proteins which are ut i l ized by the cel l for its 
betterment. 
Structure and Antigenicity of DNA 
3ames D. Watson and Francis Crick proposed their double helical 
model for DNA in 1953 on the basis of X-ray di f f ract ion studies. Analysis 
of d i f f ract ion pattern showed that DNA can exist in two forms: as 
right handed B-DNA, which is stable at a relat ive humidity of about 
92 percent and as A-DNA which appears when the relat ive humidity 
falls to about 75 percent. There are two kinds of double-ring purine 
bases, adenine (A) and guanine (G), and two kinds of single-r ing pyrimidine 
bases, cytosine (C) and thymine (T). The base pairs are held together 
by hydrogen bonds. Adenine normally is paired wi th thymine by two 
hydrogen bonds and guanine is paired wi th cytosine by three bonds. 
The two points of attachment of a base pair to its sugar ring do not 
lie direct ly opposite each other across the pair, and this is important 
for the geometry of a DNA double-helix. The edge of the base pairs 
along which the angle between attachment is less than 180 degrees 
is called the minor-groove edge, and the one forming an angle larger 
than 180 degrees is the major-groove edge. B-DNA has an average of 
[2] 
10/10.5 base pairs per turn of the helix, wi th a spacing of 3.^ * A along 
the helix axis f rom one base pair to the next. The A-hel ix has closer 
to 11 base pairs per turn, and because of the way the t i l ted • base pairs 
o 
are stacked, the distance along the axis is only 2.9 A per base pair. 
The right handed B-DNA is about 2 mm thick. 
Since the discovery of B-DNA reactive antibodies in human SLE 
and its murine equivalent (Robbins et a l . , 1957) and its cl in ical significance 
in the disease, the biochemical and immunochemical approach of the 
investigators working wi th this molecule have always faced problem 
whenever this macromolecule was used as immunogen. Exogenous native 
B-DNA has not been immunogenic in experimental animal. Even MRL 
mice, which are genetically programmed to produce anti - B-DNA antibodies 
"spontaneously", do not respond to exogenous DNA and i t did not result 
in increased anti-native DNA antibody production above the level that 
resulted from injection of adjuvant alone (which does cause some increase) 
(Madaio et a l . , 198^^). Later normal animals immunized wi th DNA, including 
DNA complexed wi th adjuvant, show only l imi ted antibody production 
which is almost exclusively directed to single stranded DNA (ssDNA) 
(Plescia et a l . , 196^*). The f i rst experimental ant i -DNA antibodies appeared 
only in 1960, in the form of antibodies to denatured (single stranded) 
DNA of the T-even bacteriophages (Levine et a l . , 1960). By contrast, 
double stranded RNA, RNA-DNA hybrid, t r ip le helical RNA and DNA 
analogues, and double helical polydeoxyribonucleotides that di f fer f rom 
average B-DNA structure, such as poly (dG). poly (dC) have been found 
to be immunogenic (Stollar 1973, 1975, 1986; Anderson et a l . , 1988). 
Injection of histone-DNA complexes yielded some anti-histone but not 
ant i -DNA antibodies (Stollar and Ward, 1970); nor did immunization 
wi th isolated nucleosomes induce ant i -DNA antibodies (Einck et al . , 
1982). A monoclonal antibody from animal immunized wi th a duplex 
DNA, poly (dT-dC). poly (dG-dA) gave a weak cross reaction wi th native 
DNA (Lee et a l . , 1985). Recently, injection of bacterial native DNA 
into normal mice induced antisera that bound native bacterial but not 
mammalian DNA (Gilkeson et al . , 1989b). However, the sera reacted 
[3] 
with denatured DNA from both sources. Injection of BK virus into rabbits 
induced antibody to both native DNA and histone (Flaegstad, 1988). 
Antibodies induced by 5-methylcytosine also include some populations 
that react wi th a native circular XP 12 phage DNA that is rich in 
5-methylcytosine content (Adouard et a l . , 1985). The modif ied portion 
of this base would be accessible to antibody in the major groove and 
there is evidence to show that a portion of antibody's combining site 
can enter the major groove and interact wi th accessible surfaces of 
bases (StoUar, 1986). Using a highly sensitive avidin-biotin micro ELISA, 
the base specific binding of adenosine antibodies to double stranded 
DNA has been reported (Vaishnav and Antony, 1990). 
To explain the unexpected presence of ant i -DNA antibodies in 
the sera of normal subjects, i t has been proposed that antibodies that 
are highly specific for bacterial DNA arise as part of the overall host 
response to infections by these organisms. In this sett ing, bacterial DNA 
would be recognized as foreign because of the presence of sequence 
arrays, structural features, or higher order conformations that are not 
usually present in human DNA. Further studies have shown that bacterial 
DNA differs f rom mammalian DNA in its content of pyrimidine clusters, 
patterns of base methylat ion, and undoubtedly, in many of its coding 
sequences (Wells, 1988; Szybalski et a l . , 1966; Weils et a l . , 1977; Cheng 
et al . , 1985). 
Types of DNA within B-Family 
The B-DNA structure per _s£ is a poor immunogen. There are 
certain right handed double stranded polydeoxyribonucleotides which 
dif fer slightly from the average B-DNA helix and are immunogenic beyond 
the adjuvant induced autoantibody expansion (Madaio et a l . , 198^*). The 
immunogenicity itself is an indication that they di f fer in structure from 
the average B-DNA. Fufther, nearly all of the antibodies generated 
recognize those differences almost uniquely; they react wi th immunogen, 
but very weakly or not at all with DNA. This again indicates the existence 
of structural differences in the helices. The B-form of synthetic 
polydeoxyribonucleotides have been found to be immunogenic and recognize 
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the difference between them and native B-DNA. These polymers include 
poly(dG). poly(dC) (Stollar, 1970); poly (dT-dC). poly (dG-dA) (Lee et 
a l . , 1985); poly (dA). poly (dT) (Diekmann and Zarl ing, 1987; Arnot t 
et a l . , 1983); poly (dG-dC) (Zarling et a l . , 1987). The other right handed 
structure in natural DNAs are A- and C-DNA which are found on changing 
the humidity and salt conditions (Arnott and Hukin, 1972; Arnot t and 
Seising, 1975). Double stranded RNA and RNA-DNA hybrid take on the 
A- or A- l ike form (Spencer et a l . , 1962; Milman et a l . , 1967). The sequence 
(dC-dA) .(dG-dT) is the most abundant purine-pyrimidine dinucleotide 
repeat in eukaryotic genome (Weber, 1990). Relatively sliort (approxitTiately 
50 bp) stretches of this sequence occur, on average, at a frequency 
of once 30 to 100 kb in all eukaryotic genomes thus far examined, 
from yeast to human (Hamada et a l . , 1982). Studies on the chromatin 
structure of the potential Z-forming sequence (dT-dG) .(dC-dA) has 
revealed evidence for an "alternating B" conformation on the nucleosomal 
surface (Gross et a l . , 1985). It is possible that the al ternat ive helical 
conformation of these sequences yields a dist inct ive structure in the 
nucleus that is recognized by proteins functioning in recombination and 
replication events. Because these sequences exhibit length polymorphism, 
they represent a new rich source of informative genetic markers (Weber 
and May, 1989). An "alternating B" structure has been proposed for 
poly (dA-dT).poly(dA-dT) in solution based on DNase I cleavage pattern, 
proton and 31 p nuclear magnetic resonance (NMR) spectroscopy, and 
X-ray fiber d i f f ract ion (Klug et al.,1979). The synthetic deoxyoctanucleotide 
d(G-G-G-G-T-C-C-C) crystall izes as an A-type DNA double helix containing 
two adjacent G-T base pair mismatches (Kneale et a l . , 1985). Also, 
the potential ly Z-DNA forming sequence d(GTGTACAC) crystall izes 
as A-DNA (3ain et a l . , 1987). Poly(dG).poly(dC) sequences, under torsional 
stress, induce an altered DNA conformation upon neighboring DNA sequences 
and such altered DNA structures may play an important functional role 
in chromatin (Shigematsu and Kohwi, 1985). 
Conformation Variant of B-DNA : Z-DNA 
There have been many attempts to propose alternat ive models 
for DNA other than right-handed double helical model. In fact . Crick 
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and Watson (195^) ruled out the possibility of a left handed structure 
for DNA because they could not build a left handed double helical 
model for DNA. In 1965, Fuller et al., had indeed built a left handed 
B-DNA, but could not build a left handed model for A-DNA. The possibility 
of a left handed structure for DNA was ruled out since the transition 
R ^ '*A could not be possible in fiber if a left handed model for B-
DNA and a right handed model for A-DNA were assumed. 
The discovery of left handed Z-conformation of DNA has led 
to a renaissance of interest in DNA structure and polymorphism (Pohl 
and 3ovin, 1972; Wang et al., 1979). The extensive research efforts 
aimed at understanding the structural details and possible biological 
significance of the altered conformation has so far resulted in furnishing 
only a limited information (3ovin et al., 1983; Rich et al., 1984; Sehgal 
and All, 1990; Hasan et al., 1991; Alam and Ali, 1992). The DNA sequences 
shown to promote the formation of left handed Z-DNA ^ vivo and 
in vitro have been implicated in increased frequencies of genetic 
recombination in bacteria (Murphy and Stinger, 1986), yeast (Treco and 
Arnheim, 1986) and mammalian systems (Bullock et al., 1986). Segments 
of DNA with alternate d(GpC) sequences are most prone to form 
Z-DNA, the next most effective sequence being d(GpT) . Other sequences 
in which the perfect alternate is not preserved can also adopt the Z-
conformation (Klysik et al., 1981; Nordheim et al., 1982; Haniford and 
Pulleyblank, 1983; Nordheim and Rich, 1983). Nevertheless, a strictly 
alternating purine-pyrimidine is neither necessary nor sufficient (McLean 
et al., 1986; Singleton et al., 1983; Kilpatrick et al., 198^; Ellison et 
al., 1985). It has also been shown that stretches of poly(dG-dC) sequences 
do not contribute significantly to the presence of Z-DNA in fixed polytene 
chromosomes of Drosophila melanogaster (Nordheim et al., 1986). Membrane 
hybridization experiments and screening of data banks have shown that 
d(GpT)^ long sequences (30 > n > 1) are generally dispersed in many if 
not all genomes. Long d(GpC) sequences are seen less frequenly (Hamada 
and Kakamaga, 1982; Hamada et al., 1984; Rich et al., 198^^). 
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Z-DNA, first described at the atomic level for the sequence 
(dC-dG), by Rich and his colleagues (Wang et al., 1979), is a prototype 
left handed double helix whose structural properties differ significantly 
from those of classic B-form DNA. Z-DNA contrast with B-DNA not 
only in its left handed helical sense, but in twist ('—>12 versus 10.5 
0 0 
base pairs per turn), helix diameter ( |8 A versus 20 A), number of helical 
grooves (1 versus 2) and structural repeat unit (dinucleotide versus 
mononucleotide) (Wang et al., 1979; Drew et al., 1980). In addition, 
the purine residues of Z-DNA are rotated 180° about the glycosidic 
bond from the anti- to the syn-conformation. Jji vitro analysis have 
demonstrated that linear duplej< (dG-dC) sequences can adopt the left 
handed Z-conformation when subjected to elevated ionic strength (Pohl 
and 3ovin, 1972; Patel et al., 1979; Klysik et al., 1981), or modification 
of either guanine or cytosine residues (Sage and Leng, 1980; Lafer et 
al., 1981; Behe and Felsenfeld, 1981; Klysik et al., 1983). Other DNA 
sequences with alternating purine-pyrimidine residues, including poly(dA-
S dT) and poly (dT-dG).poly(dC-dA), exhibit fiber structures that are 
compatible with left handed Z-form as well (Arnott et al., 1980). In 
addition, the B- to Z-transition can be induced when either (dG-dC) 
or (dT-dG) . (dC-dA) sequences are embedded in a B-DNA background 
n n ^ ° 
in recombinant plasmid or eukaryotic genome (Singleton et al., 1982; 
Nordheim and Rich, 1983; Haniford and Pulleyblank, 1983; Gross et 
al., 1985). The above sequence and certain others that contain alternating 
purine-pyrimidine residues have been shown to adopt the left handed 
Z-DNA conformation _iri vitro when subjected to negative torsional stress 
or elevated ionic strengths (Gross et al., 1985). 
In 198^, Mura and Stollar showed the ability of different lysine rich 
histones to cause varying conformational changes in the condensation 
of chromatin in DNA regions of highly biased base sequence. Recently, 
it has been shown that complexation of poly(dA-dC).poly(dG-dT) with 
spermidine and spermine could significantly alter the immunogenicity 
of this polynucleotide and produce antibodies that reacted with Z-DNA 
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form of brominated poJy(dG-dC).poJy(dG-dC) in addition to the immunizing 
antigen. That the immunizing antigen has presented the features of 
2-DNA was shown by its binding to monoclonal ant i -Z-DNA antibodies 
(Z 22) (Gunnia et al . , 1991). 
The results so far have failed to detect Z-conformation in calf 
thymus DNA (Ct-DNA). But in 1990, Hasan and Al i reported that when 
Ct-DNA was brominated under high salt (kh'\ NaCl) conditions i t presented 
the features of Z-DNA. The Z-l ike conformation was retained even 
after the removal of salt. The Ct-DNA is heterogeneous in sequence 
and microheterogeneity exist in B-structure (Hutta c>t a l . , 198^! Saniord 
et al . , 1988). The B-form of poly(dG-dC).poly(dG-dC) lacks most of this 
heterogeneity (Drew et a l . , 1981). The biochemical properties of Z-
DNA, cruci forms, bent DNA, anisomorphic DNA, oligopurine-oligopyrimidine 
structures, etc., have been the subject of numerous _iri_ v i t ro investigations 
(Wells and Harvey, 1987; Wells, 1988; Rich et al . , 198^). Z-DNA cannot 
be incorporated within core particles, except at their te rmin i , and 
that a transit ion from B- to Z-form _m vivo might result in a signif icantly 
altered local placement of nucleosomes (Garner and Felsenfeid, 1987). 
Immunochemical studies have shown that Z-DNA is a powerful 
immunogen el ic i t ing a highly specific antibody response (Lafer et a l . , 
1981). The Z-conformation of DNA was determined in interbands of 
polytene chromosomes (Nordheim et a l . , 1981) and then in banded regions 
(Arndt - 3ovin, et a l . , 1983), in nuclei of protozoa (Lipps et a l . , 1983), 
cells of rat tissue (Morgenegg et al . , 1983) and in metaphase chromosomes 
(Viegas-Pequignot et a l . , 1983). Both polyclonal and monoclonal antibodies 
specific for Z-DNA have served as sensitive reagents for the detection 
of Z-epitopes by relatively simple antigen-antibody binding assay (Lafer 
et a l . , 1981; Malfoy et a l . , 1982; Zarling et a l . , 198^ ;^ Pohl et a l . , 1982; 
Hanau et a l . , 198^). Although, the precise amount of Z-DNA present 
in l iving cells has not been established, these experiments have demonstrated 
the potential for Z-DNA formation in chromatin and have helped xo 
identify the conditions under which the transit ion can occur. Alongwith 
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studies of isolated DNA, these experiments have also demonstrated the 
role of torsional stress of supercoiling in determining the transition 
from B- to Z-DNA (DiCapua et al., 1983; Hill at al., 198^; Robert-
Nicoud et al., 198^ ;^ Peck et al., 1982; Haniford and Pulleyblank, 1983; 
Singleton et al., 1982). With monoclonal antibodies that show selectivity 
for particular base sequences in Z-DNA form (Zarling et al., 198^; Moller 
et al., 1982; Lee et al., 198^), it becomes possible to explore further 
what kind of sequences may or may not be responsible for Z-DNA formation 
in the chromosomes. 
The qualitative impression from the experiments is that 
the prokaryotic DNA seems to form Z-DNA more readily than the eukaryotic 
DNA. This may be a consequence of the markedly reduced frequency 
of C-G sequences in eukaryotic DNA compared to prokaryotic. The 
reduction may be related to the methylation of C-G sequences at 5-
position of cytosine found in eukaryot es but not in prokaryotes. The 
spontaneous deamination of methylated cytosine residues leads to the 
thymine which would cause considerable biological confusion. The reduction 
of C-G sequences in eukaryotic DNA down to approximately 10% of 
what is observed in prokaryotic DNA may lead to Z-DNA being found 
less frequently in eukaryotic DNA. A notable difference between these 
two systems is the presence of the middle repetitive DNA sequences 
d(CA/GT) n ^ 50, which occur frequently in eukaryotic systems and 
are entirely absent in prokaryotes. 
Possible Biological Role of Z-DNA 
Conformational diversity of the DNA helix appears to be used 
quite extensively by living organisms with regard to protein-DNA recognition 
and thus function (Traverse, 1989). In several cases DNA recognition 
by proteins seems to rely heavily-if not entirely on DNA conformations 
and flexibility as opposed to base sequence £££ _se (Otwinowski et al., 
1988; Goodman and Nash, 1989). Transcription by RNA polymerase is 
terminated by left handed (dC-dG) tracts (Peck and Wang, 1985). 
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Further work shows that transcription is associated with Z-DNA formation 
with a substantial increase in the binding of ant i -Z-DNA antibodies in 
metaboiically active permeabilized mammalian cell nuclei (Wit t ig et 
al . , 1991). The question that naturally arises is what physiological processes 
act in vivo to generate the negative supercoiiing (which faci l i tates Z-
DNA formation) that is continuously being removed by the act iv i ty of 
topoisomerase I (Zhang et al , , 1988). Wit t ig et al . (1991) have suggested 
that transcription is actually associated with a marked increase in the 
leveld of ant i -Z-DNA antibody binding. This may be one of the major 
physiological processes that generate negative supercoiiing and thus 
stabilizes Z-DNA formation in the intact cel l . Liu and Wang (1987) 
have suggested that RNA polymerase movement generates negative super-
coiiing upstream from the transcription site. 
Reactive Oxygen Species and Genetic Apparatus 
Free radical reactions are irreversible (Pryor, 1966; Nohebel and 
Walton, \37^) and ubiquitous in l iving organisms (Harman, 1981, 1986). 
Enzymatic reactions serving as sources of free radical reactions (Pryor, 
1966; Nohebel and Walton, 197'f) include those involved in the respiratory 
chain, in phagocytosis, in prostaglandin synthesis, and in cytochrome 
P-^50 system (Harman, 1988), Free radicals also arise in the non-enzymatic 
reaction of oxygen with organic compounds as well as those in i t iated 
by ionizing radiation (Ara et al . , 1992). iViajor sources of endogenous 
oxygen radicals are hydrogen peroxide (Chance et al. , 1979) and superoxide 
(Fridovich, 1982) generated as side products of metabolism, and the 
oxygen radical burst from phagocytosis after viral or bacterial 
infection or the inf lammatory reaction (Hal l iwel l , 1982), Observation 
of unique DNA-oxygen free radical reaction products formed in vivo (Floyd 
et al . , 1986; Frenkel et al . , 1986; Kasai et al . , 1986) appear to be impor-
tant, not only to demonstrate direct proof of their presence in vivo, but of 
greater significance, the lesions formed are 
important aspect ref lect ing the mechanism of 
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oxgen free radical mediated DNA damage. Oxidative damage is,common and DNA , 
proteins and lipids are all at risk and therefore oxygen free radicals 
are thought to be linked to many diseases (Pryor, 1987). Normal oxidative-
damage to mitochondrial and nuclear DNA has been observed to be 
caused by excited oxygen species, which are produced by radiation or 
are by-products of aerobic metabolism. Normal cellular metabolism has 
been known to generate oxygen species as hydrogen peroxide, hydroxyl 
radical, singlet oxygen, and hydroperoxy radical (Cerrut i , 1985). Moreover, 
superoxide radical and hydrogen peroxide are produced by act ivated 
phagocytes which are essential for the ki l l ing of many bacterial strain^ 
(Babior, 1988). Exposure of cells to visible light may enhance normal 
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cell concentrations of hydrogen peroxide (I x 10" M), hyperbaric oxygen 
and metabolism of certain dietary carcinogens lead to hydrogen peroxide 
acceleration. 
The monitoring of macromolecular damage in tissues f rom humans 
exposed to chemical substances that interfere wi th DNA is being actually 
pursued to explain the origin of antibodies in autoimmune dlsoders. 
It is most probable that the etiological basis for oxygen free radicals 
as contr ibuting factors in the development of several pathological conditions 
resides in their action on the genetic apparatus (Schneider et a i . , 1989). 
Oxygen free radicals have been known to cause damage to nucleic acids 
(Wallace, 1987; Stoewe and Prutz, 1987) and hydroxyl radicals have 
been implicated in the etiology of many human diseases (Hal l iwel l and 
Gutteridge, 1989). The excessive concentration of the -OH overcome 
normal defense mechanisms and leave the DNA at risk from oxidative 
modif ication (Cotgreave et al . , 1988) of deoxyribose, pyrimidines and 
purines (Von Sonntag, 1987). The oxidized nucleic acid base 8-hydroxyguano-
sine is present at a level of 130,000 bases in nuclear DNA and per 
8,000 bases in mitochondrial DNA (Richter et al . , 1988). The unique 
thing about 8-hydroxyguanosine is that i t does not stop repl icat ion: 
but i t might be relat ively benign, although it does cause misreading 
at 8-hydroxy-2'-deoxyguanosine residue itself and at the neighboring 
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base (Kuchio et a l . , 1987). Formation of 8-hydroxy-2-deoxyguanosine 
either in DNA or f rom the free nucleoside deoxyguanosine (dG) has 
been shown to be mediated by hydroxyl free radicals (Kasai and Nishimura, 
198^^; Floyd et a l . , 1986, 1988) as well as by certain other reducing 
substances including hydrazines (Kasai and Nishimura, 198^*3), polyphenols 
(Kasai and Nishimura, 1984b), and intermediates in carcinogen metabolism. 
Recent studies have demonstrated the existence of 2-hydroxyadenine 
(isoguanine) in isolated human chromatin after its exposure to assay 
mixture of Nickle (II) and Cobalt (II) and hydrogen peroxide (Nackerdien 
et al . , 1991). 8-hydroxyadenine have been isolated from the DNA in 
cancer of the female breast (Malins and Haimanot, 1991). The origin 
of the 'OH that potential ly init iates the base modif icat ion is unclear, 
although one possibility is that this radical arises from hydrogen peroxide 
generated through the cytochrome P-450-mediated oxidation of estrogen 
(Deodutta et a l . , 1991). Hydroxyl radicals produced by copper (II) plus 
hydrogen peroxide has been shown to cause site specific DNA damage 
at polyguanosines resulting in single and double strand breaks and al terat ion 
in the structure of guanosines (Sagripanti and Kraemer, 1989). Guanine 
has previously been shown to be the target for af latoxin (Muench et 
a l . , 1983), nitrogen mustards (Mattes et a l . , 1986), anti tumor agents 
(bleomycin, neocarcinostatin, cis-platin) (D'Andres and Haseltine, 1978), and 
antibiot ic (tetracycl in) action (Piette et a l . , 1986). 
DNA damage involving • OH would be relat ively favored in diseases 
where copper concentration is elevated such as Menke's syndrome (Sone 
et al . , 1987), Wilson's disease or certain neoplasms (3endryczko et a l . , 
1986). In normal cells Cu (I) would be oxidized mainly by oxygen with 
l i t t le -OH formation and DNA damage. In tumorr cells, the oxidation 
of Cud) by hydrogen peroxide would be favored resulting in DNA damage 
(Sagripanti and Kraemer, 1989). Trace metals such as copper and iron 
which are present in biological system may interact wi th act ive oxygen 
species to damage DNA (Sagripanti et a l . , 1987; Imlay et a l . , 1988). 
In the presence of trace amounts of transit ion metal (M) ions (Fe , 
Cu ) found in biological system can part icipate readily in Fenton-l ike 
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reactions resulting in the prodution of 'OH which are short l ived but 
extremely reactive with their bioenvironment, 
M ' ^ ^ H2O2 > M ^ " " ' ^ " . OH +.OH 
Under normal circumstances the concentration of reduced metal ions 
in chromatin would be expected to be low. Consequently, the production 
of a high local density of lesions in DNA by . OH radicals derived from 
the Fenton reaction wi l l depend on a large proportion of the potential ly 
reactive metal ions being in the reduced state or capable of being reduced 
by an intr insic mechanism or by reductants introduced from outside the 
cell (Jonas et a l . , 1989). Studies have shown that bacterial k i l l ing by 
hydrogen peroxides is enhanced when bacteria (Staphylococcus aureus) 
are grown for several days in an iron-rich environment in order to raise 
intrinsic iron concentrations (Repine et al . , 1981). Measurement of 
DNA damage in the presence of an excess of DNA and 1,10-phenanthroline 
has been employed as a sensitive assay to measure the avai labi l i ty of 
copper ions in human body fluids (Gutteridge, 198^ ;^ Gutteridge et a l . , 
1985; Evans et a l . , 1989; Dizdaroglu et a l , 1990). Overal l , the DNA 
damage seems to be produced by a Fenton-type mechanism in which 
transit ion metal ions are cycled by f i rst being reduced by superoxide 
and then oxidized by hydrogen peroxide. The DNA damage _in_ vi vo may 
be due to a site-specific generation of this • OH upon the DNA itself. 
This means that either the DNA has transit ion metal ions bound to 
i t _m v i t ro, or that the oxidative stress liberates such metal ions that 
rapidly bind to the DNA (Dizdaroglu et a l . , 1987). Chromosomal proteins 
may act as radical scavengers in reactions induced by ionizing radiation 
(Rotl RotI et a l . , 1974). Moreover, the iron binding proteins transferr in 
(present in plasma) and lactoferr in (secreted by neutrophils) are far 
from saturated with iron \n_ vi vo (except during iron overload), and 
can bind metal ions liberated from other proteins, thus helping to diminish 
damaging radical reactions (Hall iwell and Gutteridge, 1986). Despite 
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all the protect ive measures taken care by biological system, the free 
radicals generation seems to continue because in nature every reaction 
is liable to be altered by changes in normal physiological processes. 
Recently, Jiang &. Chen (1992) have shown decreased act iv i ty of superoxide 
dismutase (SOD) in SLE patients which resulted in elevated levels of 
free radicals. The excessive level of free radicals in SLE than those 
in normal persons, probably contr ibuting to the production of autoantibodies. 
These free radicals may play an important role in the pathogenesis 
of SLE possibly due to diminished SOD act iv i ty . 
Polyamines-DNA Nexus 
Polyamines are ubiquitous polycationic metabolites of prokaryotic 
and eukaryotic cells. These polycations are known to play c r i t i ca l roles 
in the regulation of major functions in cell growth, cel l d i f ferent iat ion 
and biosynthetic pathways (Tabor and Tabor, \32,U; Pegg, 1986, 1988; 
Schuber, 1989). Polyamines are found to be associated wi th ribosomes 
and membranes. The precise function played by these molecules inside 
the cell is not ful ly understood yet they exert an antimutagenic ef fect , 
they also prevent dissociation of 70S ribosomes to 30 S and 50S components, 
and they increase the resistance of protoplasts to osmotic lysis. Polyamines 
stimulate translation ( init iat ion and elongation) of the peptide chain 
and are implicated in maintaining translational f idel i ty , ribosomes structure 
and stabil i ty (Marton and Morris, 1987) thus markedly influencing protein 
synthesis in both prokaryotes and eukaryotes. In various growing tissues 
polyamine synthesis accompanies or precedes nucleic acid synthesis (Heby 
et a l . , 1976; McCann et a l . , 1972). The increased synthesis of RNA 
also depends on the st imulating ef fect of polyamines on RNA polymerase. 
The concentrat ion of polyamines is elevated in the biological fluids 
and tissues in a number of disease states such as cancer, sickle cell 
anemia, cystic fibrosis, psoriasis and systemic lupus erythematosus (Puri 
et al . , 1978; Gunnia et a l . , 1991). Similarly, the polyamine levels in 
the spleen cells of MRL-lpr/ lpr mice are about three fold higher than 
that in spleen cells of normal mice (Bowlin et a l . , 1986; Thomas and 
Messner, 1989). 
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Spermidine and spermine are known to be distributed widely in 
nature. Spermine is the most abundant polyamine found in animal cells 
(Tabor and Tabor, 198'f). Spermidine or spermine is essential for the 
aerobic growth of Saccharomyces cerevisiae (Balasundaram et a l . , 1991). 
The amout of spermidine varies inversely with the amount of Mg 
in ribosomes, and 30S and 50S ribosomal subunits remain associated 
in the absence of Mg if spermine is present. 
Because of protonated amino groups (at physiological pH values), 
polyamines are known to bind to negatively charged cellular molecules 
such as nucleic acids. The interaction of polyamines wi th nucleic acids 
may be responsible in part for the biological functions of polyamines 
(Basu et a l . , 1989). Thermophilic bacteria growing under the extremes 
of heat are known to produce a variety of polyamines to protect their 
genetic material from denaturation (Oshima, 1982). The polyamines 
composition of the extreme thermophile depends on growth temperature 
(Oshima and Baba, 1981). The thermophil ic cells grown at an optimum 
temperature (75 °C) contain two novel tetramines, thermine (Oshima, 
1975) and thermospermine (Oshima, 1979). The interact ion of polyamines 
with DNA produces profound changes in the structural organization and 
react iv i ty of DNA. These include the stabil ization of double stranded 
DNA, collapse of DNA into toroids and spheroids (Gosule and Schellman, 
1978; Thomas and Bloomfield, 1983), and the induction of lef t handed 
Z-DNA conformation of alternating purine-pyrimidine sequences and 
plasmids containing blocks of these sequences (Behe and Felsenfeld, 
1981; Thomas and Messner, 1988; Thomas et al . , 1991). Spermine and sper-
midine promote aggregation of DNA, increases its melt ing temperature (Tm), 
and induce B- to Z-transit ion (Feuerstein and Marton, 1987). Spermine induce 
DNA conformation that binds actinomycin D less ef f ic ient ly (D'Orazi et a i . , 
1979). On the contrary, actinomycin D is a very powerful antibiot ic that 
forms a complex with native poly(dG-dC).poly(dG-dC) sequences of DNA (3ain 
and Sobell, 1972; Sobell and 3ain, 1972). Behe and Felsenfeld (1981) 
and Thomas et ai . (1985) demonstrated that polyamines and their acetyl 
derivatives were capable of provoking B- to Z-transit ion of poly(dG-
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m^dC).poly(dG-medC). Blocks of (dA-dC).(dG-dT) which are known to 
occur widely in nature as a part of transcriptional enhancer elements 
of nnany genes undergo B- to Z- to Y- conformational transitions in 
the presence of poiyamines, thus obviating the extreme conditions (3M 
NaCl; 19% ethanol or high concentrations of NiCU) otherwise used to 
attain these conformations _ii2 vitro (Thomas and Messner, 1986). Extremely 
sensitive enzyme immunoassay technique have demonstrated that in 
the absence of poiyamines, a polynucleotide sequence poly (dG-medC). 
poly(dG-medC) does not bind to monoclonal anti-Z-DNA antibody (Z 
22) but rapid interaction occurs when poiyamines are added to the system 
(Thomas and Messner, 1988). These immunochemical studies, alongwith 
UV spectral and circular dichroism studies corroborate the above mentioned 
evidence on the binding of poiyamines to the polynucleotides. 
In 1982, Klevan and Schumaker noticed that addition of poly-
L-arginine but not poly-L-lysine to poly (dG-dC).poly(dG-dC) in high 
salt solution allows the Z-conformation to be retained upon dialysis 
to lower salt concentration. This observation suggests that the stabilization 
of the Z-DNA form is not due to simple electrostatic factors but may 
also involve some specificity in the interaction of arginine side chains 
with Z-helix. Analysis of interactions of HI and H5 histones with 
polynucleotides of B- and Z-conformations revealed two things. Firstly, 
at low protein: DNA ratios, both H) and H5 bound more Z-DNA than 
B-DNA. Secondly, the binding of Z-DNA was less sensitive to interfere 
by an increase in ionic strength (to 600 mM NaCl). Moreover, H5 histone 
caused more profound C D . spectral changes than did HI (Mura and 
Stollar, 198'^). These findings demonstrate the ability of different iysine-
rich histones to cause varying conformational changes in the condensation 
of chromatin in DNA regions of highly biased base sequence. The occurrence 
of H.is characteristic of cells that are inactive in both transcription and 
replication (Billet and Hindley, 1972; Urban et al., 1980). 
Recent studies further reiterates that natural poiyamines are 
capable of altering the immunogenicity of polynucleotides by mechanisms 
involving the stabilization of Z-DNA conformation (Gunnia et al., 1991) 
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The presence of high levels of polyamines and anti-Z-DNA antibodies 
in some lupus patients and autoimmune mice suggest the involvement 
of poiyamines in altering the topological s tate of DNA (Sehgal and 
Mi, 1990; Alam et al., 1992). 
Autoimmunity and Causative Factors 
The immune system has tremendous discrimination potential of 
self and nonself. The process of autoimmunity begins when the immune 
response is started against the self antigens. The laboratory data till 
date indicate that an age dependent loss of immune regulation might 
be a single most critical factor which is involved in the process of 
autoimmunity. It has not been found possible so far, to reproduce the 
disease by the transfer of antibody from the patient to normal individual. 
There are three models for the induction of a productive autoimmune 
process. The first is the autoimmune response to a cross reacting antigen, 
which is different from, but cross reactive with autologous determinants, 
the second is a genetic predisposition for autoimmunity through regulatory 
failure, and the third is the triggerring with bacterial mitogen of potentially 
autoimmune B cells, normally held in check by suppressor cells. 
Polyclonal stimulation might, in fact, favor antibodies against 
autologous macromolecules, since these are present in the milieu of 
activated cells and might provide the second stimulus, which results 
in the productive response by a polyclonally activated or hyperactive 
B cell (McHugh and Bonavida, 1978). There appears to be atleast two 
genetic factors that are involved in autoimmune disease. A predisposition 
may be controlled by one gene (a contoller T cell or a deviant gene 
for stem-cell development) and the disease may be precipitated by an 
external event and the reaction of this precipitating event may be under 
polymorphic genetic control. Since suppressor T cells appear to be important 
elements in the regulation of immune response, it is likely that any 
failure in the capacity to generate suppressor T cells may contribute 
to autoimmune disease. Also, genetic factors appear to affect the 
autoimmune disease of NZB mice and some forms of human SLE (Cleland 
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et al , , 1978). However, the level at which the gene controls this operation 
remains unknown. It is l ikely that the autoimnnune disease of NZB/NZW 
F1 mice is determined by two dominant genes and that one gene of 
NZB strain is on chromosome 17, but not close to H-2 (Knight ^nd 
Adams, 1975). There is also good evidence that systemic lupus erythe-
matosus is under genetic controls; 5-10% of close relatives of patients 
with SLE have lupus (Arnett and Shulman, 1976). Furthermore, mult iple 
autoimmune diseases, including SLE, have been associated wi th genetically 
determined products of the major histocompatibi l i ty complex (MHC) 
in humans, i.e. HLA (Keuning et a l . , 1976; McMichael et a l . , 1976; 
Klouda et a l . , 1979; Fye et al . , 1978; Terasaki et a l . , 1976). There is 
common occurrence of two HLA-DRW types in SLE patients (HLA-
DRw 2 and HLA-DRw 3), as well as high percentage of individuals 
with B-cell alloantigen la-715 (Decker et a l . , 1979). Increased frequencies 
of HLA-DR 3, with or without increased frequencies of DR2, have been 
found in several small groups of patients with SLE (Stastany, 1978; 
Scherak et a l . , 1979; Celada et a l . , 1980; Scherak et a l . , 1980). Sontheimer 
et al . (1981) have reported an increased frequency of DR3 in patients 
with subacute cutaneous lupus erythematosus, a subset of lupus erythe-
matosus. As in the disease of NZB mice, there appears to be a fami l ia l 
abnormality of suppressor cell function in systemic lupus erythematosus 
(Miller and Schwartz, 1979; Fauci, 1980). 
There is some evidence for an association of autoimmune disease 
with low macrophage funct ion, as assessed by carbon blockades Pass well 
125 
et a l . , 197^^), \n_ vivo clearance of 1 labeled polyvinyl pyrrolidone 
(Morgan and Soothil l, 1975) and low af f in i ty antibody (Passwell et a l . , 
197^). It also seems possible that the class of antibody provides the 
event that results in transit ion from autoimmunity to autoimmune disease. 
In New Zealand mice, the abi l i ty to clear particles was found to decline 
with increasing age (Morgan and Soothil l, 1975; Morgan and Steward, 
1976). In short, defective macrophage function may be a factor in the 
glomerulonephritis of NZB/W mice. It is possible that an age-dependent 
decline in the phagocytic function of macrophages may be direct ly involved 
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in preferential formation of low af f in i ty antibody (Steward and Powis, 
1977) but i t is also possible that poor macrophage function accentuates 
the persistence of complex between antigen and low af f in i ty antibody. 
There are growing concern about theoretical risk of autoimmune 
disease in patients undergoing PUVA treatment for psoriasis, v i t i l igo 
and mycosis fungoides. Psoralens are used in the treatmeat of human 
skin diseases (Fitzpatr ick et al . , 1982; Parrish et a l . , 1982), for probing 
nucleic acid structure (Song and TapJey, 1979; Cimino et a]., 1985; 
Parsons, 1980; Rinke et a l . , 1985; Calvet et a l . , 1982; Setyono and Pederson, 
198^) and nucleic acid-protein interactions (Cech and Pardue, 1977; 
Potter et a l . , 1980; Cimino et a l . , 1985; K i t t le r and Lober, 1988). 
Alterations in DNA resulting from the photoreaction could lead to develop-
ment of antibodies to DNA or could precipitate SLE (Hasan et a l . , 
1991). There have been reports of lupus-like syndrome (erythema) fol lowing 
PUVA therapy (Mill ins et al . , 1978; Eyason et a l . , 1979). In a recent 
study, cel l membrane DNA has been looked as a new suitable target 
for psoralen photoaddition (Gasparro et a l . , 1990). 
Systemic Lupus Erythematosus 
Systemic lupus erythematosus (SLE) is a multisystem autoimmune 
disease characterized by a myriad of cl inical manifestations and mult iple 
autoantibodies (Provost, 1979; Hahn, 1980). The origin of autoantibodies 
in SLE is an enigma poised on the verge of solution. The riddle has 
been a taxing one because lupus serum contains a bewildering variety 
of autoantibodies against nucleic acids (notably DNA), nucleoprotejns, 
cell surface antigens and phospholipids. Such extensive diversity in the 
serological abnormalities of the disease is await ing a def ini te mechanism 
of antigen act ivat ion (Harley and Scofield, 1991; Brigido and Stollar, 
1991; Fronek et a l , 1990). 
While detection of anti-dsDNA antibodies remains the most reliable 
parameter to define the disease, antibodies to DNA have also been 
found to be associated with the nephritis of SLE and are thought to 
play a pathogenic role therein. Association of other autoantibodies in 
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many pathological conditions have been presented in Table 1. It is envisaged 
that certain subpopulation of DNA antibodies may be more pathogenic 
than others. Considerable evidence has accumulated to show that both 
quali tat ive and quanti tat ive differences in the antibodies to DNA are 
important in the production of nephritis in SLE patients (Valle et a l . , 
1985). Antibodies to dsDNA are relatively restr icted to IgGl and IgG3 
subclasses whilst antibodies to ssDNA were equally distributed throughout 
the four subclasses i.e. IgGI , IgG2, IgG3 and IgG^^ f. 
Granholm and Cavallo (1990) have proposed that prolonged circulat ion 
of immune complexes (between DNA and ant i -DNA autoantibodies) due 
to various altered immune functions contributes to nephritis in MRL/ lpr 
mice. In human SLE, the early deposits of immune complexes (IC) are 
found in the mesangium and can be detected even before cl in ical or 
laboratory manifestations of renal involvement are evident (Cavallo 
et a l . , 1977). Theoretically altered blood cell carrier functions could 
at t r ibute to nephritis by allowing large amounts of ICs to remain unbound 
(free) in the circulat ion. Such ICs are thought to localize more readily 
in tissues because they circulate close to the plasma-endothelial face 
and can be precipitated or entrapped in the microcirculat ion (Schifferl i 
and Taylor, 1989). Delayed removal of ICs from the circulat ion is thought 
to favor their deposition in tissues (Schifferl i and Taylor, 1989). The 
biologically act ive, (pathogenic) immune complex systems that have been 
implicated in nephritis of autoimmune mice, i.e. DNA- ant i -DNA (Dixon, 
1987), gp 70-an t i -gp 70 (reviewed by Cavallo et a l . , 1985) and RNA 
polymerase I - an t i -RNA polymerase I (Stetler and Cavallo, 1987), could 
lend itself to localization in the kidney as preformed ICs, as ICs formed 
in situ, or both. Lupus prone mice, and many immunologically normal 
mice, have relat ively high concentrations of a serum glycoprotein of 
molecular weight 70 kD (gp 70). This glycoprotein is related structural ly 
and immunologically to the envelop glycoprotein of murine retroviruses 
(Yoshiki et a l . , 197^; Strand and August, 1976; Lerner et a l . , 1976; 
Elder et a l . , 1977; Hara et al . , 1981). It is synthesized in liver and 
it behaves like an acute phase reactant (Hara et al . , 1982). More 
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TABLE 1 
Autoantibodies Associated with Clinical Findings^ ' 
Autoantibody Clinical finding 
Anti-dsDNA 
Ant i -P 
Ant i -Ro 
Ant i -La 
Antiphospholipid 
Anti-Sm 
Anti-nRNP 
Nephritis 
Psychosis 
Lymphopenia 
Thrombocytopenia 
Interstitial pneumonitis 
Photosensitive skin rash 
Congenital heart block 
Neonatal lupus dermatitis 
Absence of nephritis 
Congenital heart block 
Neonatal lupus dermatitis 
Intravascular thromboemboli 
Miscarriage 
Thrombocytopenia 
Isolated central nervous system 
lupus 
Myositis 
Raynauds' phenomenon 
Interstitial pneumonitis 
Capillary dropout 
Sclerodactyly 
*Source: Harley, 3.B. and Scofield, R.H. (1991) 3. Clin. Immunol. 
11, 297-316 
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importantly only lupus prone mice develop autoantibodies to gp 70. Part 
of their circulat ing gp 70 is complexed wi th IgG (Izui et a l . , 1979, 
1981a, 1982) and the serum concentration of such complexed (heavy) 
gp 70 correlates with the progression of nephritis (Izui et a l . , 1981b, 
198^a,b). A small nuclear RNA-protein complex known as Ro/SSA binds 
autoantibody from many patients wi th SLE and Sjogrens syndrome (Reichlin, 
1981; Tan, 1982; Wasicek and Reichlin, 1982; Reichlin and Wasicek, 
1983). The frequent coexistence of autoantibodies to a cellular DNA-
binding protein complex (p70/p80) and to DNA has also been reported 
(Reeves, 1985). 
Recent findings have indicated that development of autoimmune 
processes in SLE is accompanied by autoantigen driven production of 
autoantibodies but is preceded and predicted by polyclonal B-cell act ivat ion 
(Kl inman, 1990). B-lymphocytes with immunoglobulin receptor for dsDNA 
are found in normal individuals as well as in SLE patients. The act ivat ion 
of these cells in SLE may be a problem of disordered immunologic 
regulation. In human SLE both CD5 ' and CD^"*" B-cells are capable of 
ant i -DNA production, although the high af f in i ty IgG ant i -DNA antibodies 
appear to come from CD5 ' subset of B-cells (Cesali et a l . , 1989). These 
findings are consistent with a model in v^hich autoantibody production 
in lupus is ini t iated by polyclonal act ivat ion and perpentuated by autoantigen 
specific stimulation Klinman et al . , 1988, 1990). Also, the presence 
of anti-receptor antibodies in SLE and related disorders (Bennett et 
a l . , 1986a,b) suggests that the DNA receptor may be an important antigen 
in the repertoire of autoimmune responses. Indeed, two murine monoclonal 
antibody have been generated with react iv i ty towards a 30000 molecular 
v/eight DNA binding protein found on the cell surface of human leukocytes 
(Bennett et a l . , 1988). SLE patients have decreased numbers of complement 
receptors on their erythrocytes as compared to normal individuals (Miyakama 
et a l . , 1981). 
Polyspecific ant i -DNA autoantibodies (so called natural autoantibodies) 
derived from normal mice showed binding to a variety of proteins including 
act in, myosin and spectrin. Natural antibodies against tubul in, act in, 
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myoglobin, thyroglobulin, fetuin, albumin and transferr in are present in 
normal human sera (Avrameas et al . , 1981). Ant i -DNA antibodies 
have been found to interact with cytoskeletal proteins (Andre-Schwartz 
et a l . , 198^); f ibronectin (Lake et a l . , 1985; Gupta et a l . , 1988) and 
heparan sulfate (Termaat et a l . , 1990), cell surface proteins (Jacob et 
a l . , 198 *^) and different cell types ( I ron et a l . , 198^1; Faaber et a l . , 
1985). Binding with hyaluronic acid, chondroitin sulfate and heparan 
sulfate which contain repeating negatively charged units (Faaber et 
al . , 1986) have also been observed. Anti-dsDNA antibodies have been 
selectively removed from SLE serum by immunoadsorption wi th dextran 
sulfate (Kinoshita et a l . , 1989). Many dif ferent Fc-binding proteins exist 
in the biological fluids or on the membrane of various cells. Circulat ing 
proteins, such as rheumatoid factors (RF) (Nemazee and Sato, 1983), 
complement components (Clq) (Dorrington and Klein, 1983), or immuno-
globulin-binding factors (Khayat et al . , 198^*; Pure et a l . , 198^) can speci-
f ical ly interact wi th Fc portion. Studies on human SLE hybridoma autoant i-
bodies have been shown to bind major cytoskeletal f i laments that included 
intermediate f i laments, microfi laments, microtubules and centrioles 
(Senecal and Rauch, 1988). In the same study, the immunoblot results 
showed that the antigenic specif icity of intermediate f i lament reactive 
SLE hybridoma antibodies was not restr icted to vimentin (a phosphoprotein 
under hormonal regulation) (Browning and Sanders, 1981) but included 
cytokeratins and desmin. 
Monoclonal IgM ant i-DNA autoantibodies, produced by hybridomas 
prepared from lymphocytes of SLE patients have been found to bind 
to several di f ferent antigens including ssDNA (Shoenfeld et a l . , 1982, 
1983), synthetic polynucleotides (Shoenfeld et a l . , 1982), vimentin (Andre-
Schwartz et a l . , 198^^), platelets (Asano et a l . , 1985), acidic glycolipidf 
in platelets (Asano et al . , 1986) and sulfated complex carbohydrates 
(Asano et a l . , 1986). These reactivi t ies can be most simply interpreted 
as the interaction of an ant i-DNA with a conformational determinant 
or charge array in space that can be represented not only by DNA, 
but by other molecules as wel l . Besides, DNA could also interact in 
[23] 
unanticipated ways wittn other polycationic structures in the body to 
innpair cel l function or homeostasis. As a polyanion, DNA could display 
heparin like act iv i ty and disrupt c lot t ing mechanisms. 
Ant i -DNA antibodies in normal control groups have been reported 
from t ime to t ime. To explain the unexpected presence of ant i -DNA 
antibodies in normal subjects, i t has been proposed to arise as part 
of the overall host response to infections by pathogenic bacteria. In 
this sett ing, bacterial DNA would be recognized as foreign because 
of the presence of sequence arrays, structural features, or higher order 
conformations that are not usually present in human DNA. Studies have 
clearly shown that bacterial DNA differs f rom mammalian DNA in its 
content of pyrimidine clusters, patterns of base methylat ion, and undoubtedly 
in many of its coding sequences (WelJs, 1988; Szybalski et a l . , 1966; 
Wells et al . , 1977; Cheng et a l . , 1985), Together, these features could 
create local regions in bacterial DNA that are structural ly dist inct and 
rarely present in mammalian DNA. A role of ant i -DNA as protoantibodies 
in an in i t ia l defense against foreign antigenic challenge has been reported 
(Schwartz and Stollar, 1985; Pisestky et a l . , 1990). Ant i -DNA antibodies 
serve an important role in normal immunity not because they bind DNA, 
but because they are polyspecific and can bind non-DNA antigens, especially 
bacterial products. The broad reactivi t ies represent a useful in i t ia l defense 
against mult iple antigens. Furthermore, these antibodies can be mutated 
into high af f in i ty antibodies that bind more exclusively to foreign antigenic 
determinants (Naprastek et a l . , 1986). It seems clear that many ant i -
DNA are in the repertoire of normal individuals and have characterist ics 
of non-autoantibodies. Thus, the binding to a self antigen, especially 
under certain assay conditions, may not constitute a suff icient cr i ter ion 
to indicate that an antibody has pathogenic potential , or is a product 
of aberrant regulation or abnormal idiotype expression. 
In a recent study, the effect of polyamines on the immunogenicity 
of polynucleotides have been investigated (Gunnia et a l . , 1991). The 
el ic i tat ion of ant i -Z-DNA antibodies by polyamine-polynucleotide complex 
suggests a possible involvement of polyamines in the production of ant i -
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Z-DNA antibodies in hunnan SLE. The antigenic DNA may be genomic 
DNA in the serum, which has been shown to have an abnormally high 
guanine-cytosine (G-C) content (Sano and Morimoto, 1982) and an abnormally 
high occurrence of alternating purine-pyrimidine segments (Van Helden, 
1985). This phenomenon may be significant, since i t has been shown 
that segments of alternating pyrimidine-purine residues, part icularly 
poly(dG-dC) can undergo a transit ion from B- to Z-conformation (Pohl 
and 3ovin, 1972; Behe and Felsenfeld, 1981; Zacharias et a l . , 1982; 
Moller et a l . , 1984) and since it has also been shown that the Z-form 
of DNA is highly immunogenic (Lafer et a l . , 1983). if, therefore, Z-
DNA segments occur naturally in SLE patients we may expect a greater 
production of ant i -Z-DNA antibodies than ant i -B-DNA antibodies (Van 
Helden, 1985). That such ant i -Z-DNA antibodies do occur in SLE sera 
has been shown (Lafer et a l . , 1983; Sibley et a l . , 1984; Gunnia et a l . , 
1991; Sehgal and A l l , 1990). There are several reports that serum DNase 
1 levels are decreased in patients with SLE (Chitrabamrung et a l . , 1981; 
Frost and Lachman, 1968). At the same t ime i t has been suggested 
that most of immunogenic duplex nucleic acids are nuclease resistant 
(Braun and Lee, 1988). 
Antibodies to dsDNA play a key role in the pathogenesis of SLE 
and therefore considerable research ef for t over the past 25 years has 
focused on both the quantitat ive determination and the qual i tat ive 
characterization of anti-dsDNA antibodies that are found in the circulat ion 
of patients wi th SLE (Zouali and Stollar, 1986; Lau et a l . , 1991; Rauch 
et a l . , 1985; Cairns et a l . , 1989; Alam and A l i , 1992; Alam et a l . , 1992). 
Analysis has revealed that pathogenic ant i-DNA antibodies of both human 
and murine SLE are of IgG isotype and cationic in nature (Ebling dc 
Hahn,1980;Datta et a i . , 1987). Ant i -DNA antibodies induced by immunization 
of experimental animals wi th nucleic acids are highly specific for 
the immunogen (Stollar, 1980; Lafer et al . , 1983), whereas the spontaneously 
produced ant i -DNA autoantibodies in SLE tend to crossreact wi th a 
variety of ligands (Andrzejewski et a l . , 1981; Pisetsky and Caster, 1982; 
Koike et ai . , 1982; Shoenfeld et al . , 1983; Pisetsky et a]. , 1990). 
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There is increasing evidence for the mieroheterogeneity of DNA 
and the existence along the DNA molecule of diverse structures that 
differ in dinnensions and topology from B-DNA,, It has been debated, 
whether DNA from various sources differ markedly in their immunogenic 
potential. It has been shown that in mice certain bacterial single stranded 
DNA (ssDNA) and dsDNA can induce significant anti-DNA responses, 
including antibodies to dsDNA (Gilkeson et al., 1989 a,b). In fact immuni-
zation with E_. coli DNA has induced antibodies (Gilkeson et al., 1989b 
that resemble spontaneous anti-DNA antibodies of lupus mice in terms 
of their recognition of defined antigens (Pisetsky et al., 1990). In the 
year 1990, Gilkeson et al., showed that mice immunized with calf thymus 
DNA (Ct-DNA) failed to generate an antibody response to either Ct 
or E_. coli (Ec) DNA. The antibodies to Ec dsDNA did not crossreact 
with Ct dsDNA. However, immunization with Ec dsDNA did produce 
antibodies that were reactive with both Ec and C t ssDNA, possibly 
reflecting the _m vivo breakdown of some of the dsDNA antigen into 
ssDNA, and the induction of an antibody response specific for this form 
of DNA. In these experiments the crossreactive antibodies to ssDNA 
resembled those found in lupus: in contrast, the antibodies to dsDNA 
bound only the immunizing antigen and lacked activity to common dsDNA 
determinants that are characteristic of lupus autoantibodies. Fournie 
(1988) has postulated that not DNA, but DNA bound to nuclear proteins 
could also play a role in the pathogenesis of SLE. 
Monoclonal autoantibodies have been prepared that di scriminates 
nearly completely between synthetic poly(dG-dC) and poly(dA-dT) and 
protects certain restriction nuclease cleavage sites preferentially (Stollar 
et al., 1986). Arnott et al. (1983) have described variation in helical 
geometry as presentation of a "wrinkled" backbone surface, which is 
different in poly(dA-dT) and poly(dG-dC), both of which differ in precise 
dimensions from average B-DNA. Murine monoclonal autoantibody, H2^1 
binds well to native DNA but also displays several crossreactions that 
include denatured DNA, and both the B-DNA and Z-DNA forms of 
poly(dG-dC) (Stollar et al, 1986). On the other hand, H2^1 showed no 
reactivity in either direct binding or competitive binding assay, with 
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several single stranded homopolymers, [poly(A), poly(C), or poly(U)]; double 
stranded RNA [poly(A).poly(U) or poly(I).poly(C)]; DNA-RNA hybrid [poly(A). 
poly{dT)]; or triple stranded helices [poly{A).poly(l),poiy(l) or poly(A). 
poly(U).poly(U)]. Monoclonal autoantibody HZ'tl has a striking ability 
to recognize helical structural features ot poly(dA-dT) and polyCdG-
dC) that depend on base sequence. In poly(dA-dT) the adjacent ApT and 
TpA segments are not identical, as revealed by two distinct peaks in the 
P-NMR spectrunn (Patel et al., 1981); the repeating unit in this polymer 
IS a dinucleotide rather than a mononucleotide (Klug et al., 1979; Patel 
et al., 1981). H2^l also reacts with cardiolipin, which contains phosphate 
groups spaced by 3 carbon atoms but does not have purines or pyrimidines. 
This crossreaction of the antibody (H2'*l) indicates that some of the 
binding site also interacts with the phosphate backbone. To determine 
whether both heavy (H) and light (L) chains of different anti-nDNA 
autoantibodies are uniformly involved in binding to DNA, monoclonal 
mouse IgG autoantibodies, H241 and 2C10 were mixed with radiolabeled 
oligonucleotide and UV (25'l nm) irradiated for 10 min which led to 
specific covalent crosslinking of oligonucleotide to both the H and 
L chains of H2^1 but only to H chain of 2C10 (Jang and StoUar, 1990). 
The dependence of oligonucleotide-protein crosslinking on specific immune 
complex formation was demonstrated by the complete absence of crosslink-
ing to non-immune IgG even after 2 h of irradiation; by which time the 
IgG molecules themselves had become aggregated. 
Therap>eutic Approach to SLE Treatment 
Therapeutic approach to the treatment of SLE have included the use 
of corticosteriods, various cytotoxic agents, and total body irradiation (Elad 
et al., 1986). Because of the profound adverse effect of corticosteriods on 
normal functioning of the immune system due to the fundamental drawbacks 
of not distinguishing between physiological and pathological immune response, 
the recent treatment involves use of normal immunoglobulin G (IgG) (intra-
venous immunoglobulins) (Dietrich and Kazatehkine, 1990; Schwartz, 1990) and 
plasmapheresis, a new approach to interrupting the pathogenetic events in 
systemic lupus erythematosus (Lewis et al., 1992). In missile therapy 
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of SLE (Sasaki et a l . , 1985), ant i- idiotypic antibodies suppressed mult ipl ication 
of EBV transformal lymphocytes of SLE patient has been t r ied. It may 
be reiterated that despite tremendous development in understanding 
the possible mechanism involved in precipi tat ing autoimmune diseases, 
most of SLE patients are st i l l receiving corticosteroids. 
Biological Implications of Anti-Nucleic Acid Antibodies 
Anti-nucleic acid antibodies may serve as non-destructive models 
and a precise yardstick for examining protein-nucleic acid interactions. 
They may be used to follow structural changes in given nucleic acids 
or nucleoproteins. Anti-nucleic acid antibodies may also be ut i l ized as 
reagents to detect and quantitate DNA in serum and other body fluids 
(released during pathological conditions). The ant i -DNA antibody can 
be used for sensitive detection of DNA-containing structures such as 
chromatin in di f ferent tissues of man, rat , mouse, chicken, amphibia 
and insects. Cel l nuclei of various cell lines such as XLK E-A6 (Xenopus), 
RVF-SMC (rat), PTK-2 (rat-Kangaroo) and HeLa (human) show positive 
reactions. They can distinguish almost quanti tat ively among members 
of di f ferent helical famil ies (Lacour et a l . , 1973; Stollar, 1973, 1975, 
1989) and qual i tat ively among dif ferent members of helical class (Lacour, 
et a l . , 1973; Guignes and Leng, 1976; Johnston and Stollar, 1978; Nahon-
Merlin et a l . , 1980). As their specificit ies are defined these antibodies 
become useful analytical probes, serving as sensitive and specific reagents 
for detecting particular structure in complex biological mater ial including 
mammalian genome. Experimentally induced antibodies to le f t handed 
Z-DNA (Nordheim et a l . , 1981; Lemeunier et a l . , 1982; Arndt-3ovin 
et al . , 1983; Kmiec and Holloman, 198^^), double stranded RNA (Stollar 
and Stollar, 1970; Mil ler et a l . , 1975) or DNA-RNA hybrids (Rudkin 
and Stollar, 1977; Busen et al . , 1982; Alcover et a l . , 1982) have been 
able to detect corresponding structures without interference from a 
large excess of other nucleic acids. Monoclonal autoantibodies have 
been shown to protect certain restr ict ion nuclease cleavage sites on 
DNA preferential ly (Stollar et a l . , 1986). Also monoclonal anti-nucleic 
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acid antibodies are useful immunochemical tracer of a specific DNA 
conformation of utmost biological importance (Anderson et a l . , 1988). 
Recent look at the risk factors which are involved in the pathogenesis 
of SLE. Genetic, environmental, immune, and hormonal factors acting either 
directly or indirectly lead to the production of mediator substances 
like autoantibodies, immune complexes, and complement act ivat ion products 
which cause tissue destruction and disease expression. 
Factors 
Genetic 
V 
Hormonal 
Immune ^ — > 
Mediators 
Autoantibodies 
Immune complexes 
Complement 
act ivat ion 
Tissue 
destruction 
Environmental 
Objective of the Present Study 
The non-immunogenic nature of native DNA (B-form) and poly-
specjf icity exhibited by SLE anti-DNA antibodies, withd respect to mult iple 
antigen binding, s t i l l poses the puzzling questions regarding their possible 
origin. Despite this, elevated levels of anti-nDNA antibodies in act ive 
SLE continue to be diagnostic marker of the disease. As the horizon 
of polyspecif icity of SLE antibody is expanding, the scienti f ic views 
on possible origin of these antibodies is also increasing and the results 
so far reported have been unequivocally accepted. Hence, the study 
of antigen binding characteristics of ant i -DNA autoantibody is relevant 
to specify dist inct ly its polyreactivi ty with native and modified DNA 
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antigens of varying size and conformation. Well defined and characterized 
ant i-DNA antibody could be uti l ized for monitoring changing DNA confor-
mations during genetic act iv i t ies. In this study purif ied calf thymus 
DNA and its fragments of varying size were modified by bromination 
in low and high salt concentrations and were evaluated as antigen for 
binding wi th ant i-DNA antibodies. Effect of varying concentrations 
of D- and L-isomer of polylysine on B- conformation was also evaluated. 
The change in DNA conformation was monitored by UV spectroscopy 
and binding with ant i -Z-DNA antibodies. The DNA was also modified 
with lysine, furocoumarin and hydroxyl radical. Each of the modified 
antigen was systematically characterized and investigated for binding 
to ant i-DNA IgG. 
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Chemicals 
Anti-goat, anti-human, anti-mouse and anti-rabbit IgG alkaline 
phosphatase conjugates, bovine serum albumin, calf thymus DNA (highly 
polymerized), Coomassie Bri l l iant Blue G 250 (5c R 250, dialysis tubing 
(of varying diameter), ethidium bromide, Mil l ipore f i l ter {0A5 um pore 
size), Fruends' adjuvants, Hoechst dye 33258, 8-methoxypsoralen, methylated 
bovine serum albumin, nuclease 51, poly-L-glutamic acid, poly-D-lysine, 
poly-L-lysine, trinitrobenzene sulfonic acid (TNBS), Tris-(hydroxymethyl)-
aminomethane, xylene cyanole FF were purchased from Sigma Chemical 
Company, U.S.A. Dextran Blue 2000, DEAE Sephacel, DEAE Sephadex 
A-50, Ficol l 'fOO, micrococcal nuclease, poly(dG-dC).poly(dG-dC), poly(dG-
me^dC).poly(dG-me^dC), poly(dA-dT).poly(dA-dT), poly(dA-dU).poly(dA-
dU), poly(dI-dC).poly(dI-dC), poly(dA-dG).poly(dC-dT), poly(dA).poly(dT), poly 
(dG).poly(dC), poly(rG).poly(dC), poly(dA), poly(dG), poly(dC), poly(dT), poly U, 
Sephadex G 200, Sepharose '•B, protein A-Sepharose CL-'fB were the product 
of Pharmacia Fine Chemicals, Sweden. Acrylamide, ammonium persulfate, 
bisacrylamide, hydroxyapatite, N,N,N' ,N'- tetraethyl methylenediamine, Tween-
20 were obtained from Bio-Rad, U.S.A. Acetic acid, acetoni t r i le, EDTA (di-
sodium salt), glycine, hydrogen peroxide, sodium lauryl sulfate, sucrose, 
ammonium sulfate, calcium chloride, methanol, sodium carbonate, sodium 
chloride from Qualigens, India. Chloroform and liquid bromine were the pre-
paration of B.D.H. India. Isoamyl alcohol, sodium bicarbonate, zinc chloride 
were purchased from Merck, India. Ferrous sulfate and potassium chloride 
was from Sarabhai, India. Psoralen was a generous gi f t f rom C D . R . I . Luck-
now. P-nitrophenyl phosphate was obtained from C.S.I.R. Centre for Bio-
chemicals, Delhi. Cyanogen bromide was a product of S.D. f ine chemicals, 
India. Acetaldehyde was from Fluka, Switzerland, Bromophenol blue and ly-
sine monohydrochloride was purchased from B.D.H. England. DEAE Cellulose 
was obtained from Whatman, England. Perchloric acid and sodium azide were 
products of Ferak-Berl in, Germany. ELISA plates were from NUNC Denmark 
<5c Dynatech, U.S.A. Diphenylamine and ethanol were chemically pure. 
[31] 
Equipment 
Spectronic 20 (Bauch &. Lomb, U.S.A.), UV-Visible 2^0 spectro-
photometer (Shimadzu, Japan), •spectrofJuorometer RF-5W (Shimadzu, 
Japan), microplate reader MR-600 (Dynatech, U.S.A.), gel electrophoresis 
apparatus GNA-100 (Pharmacia, Sweden), pH meter L1-10T and conductivity 
bridge (ELICO, India), UV lamps having maximum emission at 25^ ^ and 
365 nm (Vilber-Lourmat, France), desk top microfuge RM-12C (REMI, 
India) were the major equipments used in the present study. 
Sera 
The normal human sera was collected from healthy subjects without 
evidence of SLE or other autoimmune disorders and it was ensured that 
the subjects were not taking any drug known to induce antinuclear anti-
bodies. The SLE sera was obtained from patients who had elevated levels 
of anti-native DNA antibodies and met preliminary criteria of the American 
Rheumatism Association (ARA) for the diagnosis of disease (Tan et 
al., 1982). All serum samples were heated at 56 °C for 30 min to inactivate 
complement which inhibits the formation of, and also dissolves, preformed 
antigen-antibody complexes (Miller and Nussenzweig, 1975; Schefferli 
et al., 1980). After decomplementation the sera was kept at -20 °C 
with 0.02 percent sodium azide as preservative. 
Determination of Protein Concentration 
Protein was estimated by the method of Lowry et al. (1951) 
and Bradford (1976). 
Protein Estimation by Folins-Phenol Reagent 
The protein estimation by this method utilizes alkali (to keep 
the pH high), Cu ions (to chelate proteins) and ta r ta ra te (to keep 
the Cu ions in solution at high pH). 
[32] 
(a) Folin-Ciocalteu reagent 
The reagent was purchased from C.S.I.R. Centre for Biochemicals, 
Delhi. Before use the reagent was diluted 1:^ wi th high purity deionised 
water. 
(b) Alkaline copper reagent 
The constituents of alkaline copper reagent were 
(i) Two percent sodium carbonate in O.IM sodium hydroxide, 
(ii) 0.5 percent copper sulphate in 1,0 percent sodium potassium tar tarate. 
The working reagent was prepared fresh by mixing components 
(i) and (ii) in the rat io of 50:1. 
(c) Procedure 
Freshly prepared 5.0 ml of alkaline copper reagent was mixed 
with 1.0 ml of protein sample. The tubes were incubated at room 
temperature for 10 min. One ml of diluted Folin-Ciocalteu reagent was 
added followed by 30 min incubation at room temperature. The absorbance 
was monitored at 660 nm. The protein content of the unknown sample 
was determined from standard plot constructed by using bovine serum 
albumin. 
Protein Estimation by Bradford Method 
This assay is based on the color change that occurs when Coomassie 
Bri l l iant Blue G 250, in acid solution, binds strongly to protein hydro-
phobically and at positively charged groups. .>. the environment of these 
positively charged groups, protonation is suppressed and a blue color 
is observed ()^max = 595 nm). 
(a) Dye pa-eparation 
Hundred mil l igram of Coomassie Bri l l iant Blue G 250 was dissolved 
thoroughly in 50 ml of 95% ethanol. To this solution was added 100ml 
of 85% (v /v ) orthophosphoric acid. The resulting solution was diluted 
to a f inal volume of 1 l i ter. On every use the dye solution was f i l tered. 
[33] 
(b) Protein assay 
Solution containing 10-100 ug protein in a volume of upto 0.1ml 
was pipetted into test tubes. The volume was adjusted to 1.0 ml with 
appropriate buffer. Five ml of dye solution was added and the contents 
were mixed by vortexing. The absorbance was taken at 595 nm after 
two min and before one hr against a reagent blank prepared from 0.1 
ml of buffer and 5.0 ml of dye solution. 
Purification of DNA 
Highly polymerized calf thymus DNA was purified free of proteins, 
RNA and single stranded regions (Ali et al., 1985). DNA solution (2mg/ml) 
in 0.1 X SSC buffer (0.015 M sodium-citrate, pH 7.3 containing 0.15 
M sodium chloride) was mixed with equal volume of chloroform-isoamyl 
alcohol (2'*:1 ratio) in a stoppered glass cylinder. The cylinder was sealed 
and the contents were mixed end-to-end gently for one hour. The DNA 
present in acqueous phase was separated from the organic layer by 
low speed centrifugation. The extraction process was repeated once 
and DNA was precipitated with two volumes of cold 95% ethanol and 
collected on a glass rod. It was dried by pressing against the wall of 
the container. The DNA thus obtained was dissolved in 0.1 X SSC buffer 
and treated with RNase A {50 ug/ml) for 30 min at 37 °C to digest 
RNA in case present. The digested DNA was precipitated, dried and 
dissolved in 30 mM acetate buffer pH 5.0 containing 30 mM zinc chloride. 
The digested sample was incubated with single strand specific enzyme, 
nuclease Si (250 units/mg DNA) at 37 °C for 30 min. The reaction 
was terminated by adding one-tenth volume of 0.2 M EDTA pH 8.0. 
The purified DNA was extracted twice with chioroform-isoamyi alcohol 
dnd reprenpitated with cold 95% ethanol. The DNA precipitate was 
dried and dissolved in required buffer. 
Determination of DNA Concentration 
DNA was estimated by diphenylamine reagent and Hoechst dye 
33258. 
DU] 
DNA Estimation by Burton Method 
Color imetr ic estimation of DNA was carried out according to 
Burton (1956) using diphenylamine, 
(a) Diphenylamine reagent 
To 750 mg of recrystall ized diphenylamine was added 50 ml of 
glacial acetic acid followed by 0.75 ml of concentrated sulphuric acid. 
The reagent was prepared fresh before use. 
(b) Assay procedure 
Varying amount of DNA in 1.0 ml was mixed wi th 1.0 ml ol 
IN perchloric acid. The tubes were incubated for 15 min in a water 
bath maintained at 70 °C. One hundred ui of 5.^3 mM acetaldehyde 
was added followed by 2.0 ml of diphenylamine reagent. The tubes were 
mixed thoroughly and allowed to stand at room temperature for 16-
20 hr for color development. Absorbance was read at 600 nm. The DNA 
concentration in the unknown sample was determined from the standard 
plot of purif ied calf thymus DNA. 
Fluorimetric Assay of DNA 
Fluorimetr ic estimation of DNA was carried out according to 
Lebarca and Paigen (1979) using Hoechst dye. The dye Hoechst 33258 
[C2-[2-(^ hydroxyphenol)-6-benzimidazolyl-6( 1 -methyl- ' f-piperazyl) benzi-
midazole] interacts wi th DNA wi th a many fold increase in fluorescence. 
(a) Reagents 
(i) 0.05 M sodium phosphate (pH 7A) containing 0.002 M EDTA and 
2 M sodium chloride, 
(ii) 200 ug/ml of Hoechst 33258 in deionized water. 
On day of use, the working dye solution is prepared by diluting 
(ii) 200-fold in solution (i). 
[33] 
(b) Method 
Solution containing 0.1-1.0 ug DNA in 0.1 ml final volume was 
mixed with 2.k ml of working dye solution. The mixture was incubated 
for 5 min at room temperature and fluorescence was read at 'fSO nm 
(^ex = 355 nm). The fluorescence of a solution containing dye plus buffer, 
but no DNA, was taken as control. 
Isolation of IgG 
The IgG was purified by ion exchange chromatography, gel filtration 
and affinity chromatography. 
(a) Preparation of crude immunoglobulins 
To 6.5 ml of fresh serum was added dropwise saturated ammonium 
sulphate solution allowing each drop to disperse before the next was 
added. When the concentration of ammonium sulphate reached about 
20% of saturation, the serum had begun to turn milky. Most immunoglobulins 
got precipitated by 35-37 percent of saturation. The precipitation was 
carried out at ^ °C. The suspension was stirred for 30 min and then 
centrifuged at 10,000 rpm for 15 min. The pellet thus obtained was 
washed 2-3 times in 35 percent saturated ammonium sulphate. Repeated 
washing of the pellet considerably reduced contamination of non-immuno-
globulins and did not lower the yield significantly. Finally the precipitate 
was dissolved in Q.0]75 M sodium phosphate buffer, pH 6.8. Ammonium 
sulphate was removed by overnight dialysis against 50Q-\Q00 volumes 
of 0.0175 M sodium phosphate buffer, pH 6.8. The dialysis fluid was 
changed several times at intervals of a few hours. 
(b) DEAE Sephacel chromatography 
Dialyzed crude immunoglobulins in 0.0175 M sodium phosphate, 
pH 6.8, buffer were loaded on DEAE Sephacel column (1.5 cm X 20 cm) 
previously equilibrated with the same buffer. The column was eiuted 
with 0.0175 M Na-phosphate and fractions were collected until the 
absorbance at 280 nm reached base line (Fig. I). First peak of the 
chromatogram was found to contain IgG. The homogeneity of isolated 
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Fig.l. Isolation of IgG from an SLE serum by DEAE Sephacel. 
Thirty five percent saturated ammonium sulphate precipitated 
serum proteins were loaded onto the column. The peaK 
fractions v;ere pooled as IgG. 
Inset: Polyacrylamide gel electrophoresis of isolated leG on 
7.5% gel. 
[37] 
IgG was confirmed by single band nnovement in SDS-polyacrylamide 
gel (Fig. 1 inset). 
(c) Purification of IgG by gel filtration 
The serum immunoglobulins were fract ionated on Sephadex G 
200 column. Immunoglobulins from serum were precipitated wi th 50 
percent saturated ammonium sulphate and processed accordingly to method 
described earl ier. The immunoglobulins were f inal ly dissolved and dialysed 
against copious volume of 0.05 M Tr is -HCl , pH 8.0 containing 0.15 M 
sodium chloride and loaded on a gravity packed Sephadex G 200 column 
(2 cm X 75 cm) previously equilibrated wi th the same buffer. The column 
was operated at a flow rate of 25 ml/hr and fract ionated immunoglobulins 
were monitored for protein at 280 nm. The IgG peak was identi f ied 
by absorbance measurements at 278 and 251 nm. A part icular property 
of mammalian IgG is that their absorbance at 278 nm is about 2.5-
3.0 higher than at 251 nm, in contrast to other serum proteins where 
this rat io is about 1-1.5 (in neutral buffers). 
(d) Affinity isolation of IgG 
Protein A-Sepharose is a popular and simple tool in the puri f icat ion 
of IgG and its subclasses. The antigen-binding region (Fab) is preserved 
in its native state as the binding occurs through Fc region of the molecule. 
Commercial ly obtained Protein A-Sepharose CL-^fB (1.5 gm) was 
swelled in 0.01 M phosphate buffered saline (PBS), pH 7 A at room 
temperature for ^8-72 hr. The swelled gel (about 5.0 mi) was poured 
into a small column (0.9 cm x 15 cm). The column was washed once 
with 0.1 M sodium-citrate, pH 3.0, to elute any bound material and 
then equil ibrated with f ive volumes of PBS. Serum diluted wi th an equal 
volume of PBS is passed through the column at a rate of about 20 
ml/hr. The absorbance of the eff luent is monitored unt i l no protein 
leaves the column. The bound IgG is eluted with 0.58% acetic acid 
in 0.85% sodium chloride (Goding, 1976). To prevent the ef fect of acidic 
elution buffer on IgG, the eluate was collected in 1 M Tr is-HCl, pH 
[38] 
8.5. Fractions containing IgG was read at 280 nm and concentration 
was determined considering I'f O.D.^„„ = 10 mg IgG/ml. 
° 280nm ° ° 
Hydroxyapatite Chromatography of Single and Double Stranded DNA 
Hydroxyapatite discriminates nucleic acids endowed with different 
secondary structures. Rigid, ordered structures having more affinity 
for hydroxyapatite than flexible disordered ones. 
The commercial preparation of hydroxyapatite was washed with 
0,01 M Na-K phosphate, pH 6.8 buffer to remove fine particles therein. 
Hydroxyapatite packed in glass column (1.5 cm x 5 cm) was equilibrated 
with 0.01 M Na-K phosphate. Native DNA dialyzed against equilibrating 
buffer was adsorbed to the column. The column was washed with ten 
volumes of equilibrating buffer, at a fiov/ rate of 10 ml/hr, to wash 
any unbound DNA. The bound DNA was eluted with increasing phosphate 
molarity of 0.125 and 0.25 M strength. Native DNA got eluted at 0.25 
M ionic strength and in the large majority of cases a complete recovery 
was obtained, as judged from A_^„ measurement. 
DNA denatured by heating for 15 min at 100 °C, at a concentration 
of 50-100 ug/ml in 0.01 M Na-K phosphate (pH 6.8) buffer, showed 
a chromatographic behaviour quite different from that of native DNA. 
The stepwise elution results show that bulk of denatured DNA is eluted 
at 0.125 M phosphate molarity. The propci , les of the main fraction 
of denatured DNA were those of single stranded DNA. A small fraction 
of denatured DNA is eluted at the same phosphate molarity as native 
DNA. 
Micrococcal Nuclease Digestion of Native Calf Thymus DNA 
Deproteinized calf thymus DNA (2 mg/ml) in 0.006 M Tris, 0.1 
M sodium chloride, 0.002 M calcium chloride, pH S.O was digested with 
micrococcal nuclease (^0 units/mg) for 2.5 min at about 37 °C. The 
reaction was terminated by adding one-tenth volume of 0.2 M EDTA, 
pH S..0. The sample, after precipitation with cold ethanol was subjected 
to nuclease SI digestion (150 units/mg DNA) for 30 min at 37 °C (Ali 
[39] 
et a l . , 1985). The resulting DNA was reprecipitated, dissolved in TBS 
(0.01 M Tris, 0.15 M sodium chloride, pH 8.0) and passed through a 
Sepharose 4B colunnn (1.5 cm x W cm) previously equil ibrated wi th 
the same buffer. The fall through fractions (^.0 ml) were collected and 
monitored for DNA content at 260 nm, using 1.0 O.D. at 260 nm = 
50 ug dsDNA/ml. Size of the DNA fragments were analyzed on poly-
acrylamide slab using Lambda DNA digest of EcoR I and Hind III as 
size marker. 
Modification of DNA 
Poly(dG-dC).poly(dG-dC), native DNA and small DNA fragments 
were treated for 1 hr wi th k.O M sodium chloride (ef fect ive concentration 
for B- to Z-DNA transition) respectively in c i t ra te buffer (0.02 M t r i -
sodium c i t ra te , pH 7.2 containing 0.001 M EDTA) at a f inal concentration 
of 100 ug/ml in 3.0 ml total volume. The same amount of polymers 
in PBS (0.01 M phosphate buffer, pH 7A containing 0.15 M NaCl) served 
as low salt control sample. The absorbance values were recorded at 
260, 280, 29 *^ and 296 nm to evaluate the absorbance rat io. The UV-
absorbance and difference spectra of both high and low salt sample 
was recorded. 
Nucleic acid polymers were brominated under high and low salt 
conditions as described by Lafer et a l . (1981). Bromine saturated water 
was prepared by mixing 0.55 ml of liquid bromine in t49.k5 ml of high 
purity dist i l led water. Bromine water (7 uL /mL DNA sample) was added 
to the DNA sample, wi th quick mixing, and kept in dark for 30 min 
at room temperature. Af ter the completion of reaction, excess bromine 
was removed by exhaustive dialysis against TBS (0.01 M Tris, pH 7.4 
containing 0.15 M NaCl). Native DNA and small DNA fragments brominated 
in high and low salt solution were designated as Br4 and BrN respectively. 
Absorbance value of brominated DNA was recorded at 260, 280, 29^ ^ 
and 296 nm against TBS, pH 7A. Average of absorption at 294 and 
296 nm divided by absorbance at 260 nm was referred to as "absorbance 
['fO] 
rat io". The ratio obtained for brominated and non-brominated poly(dG-
dC).poly(dG-dC) was used as standard to which the absorbance rat io 
for other nucleic acids were compared. The absorption spectra of low 
and high salt brominated DNAs were recorded against buffer and compared 
against the spectra obtained wi th same concentration of respective DNA 
solution. The UV difference spectra was recorded by taking equal amount 
of corresponding DNA polymer as control . 
DNA-Polylysine Interaction 
To nDNA samples (50 ug/ml), varying amount of D- and L-polylysine 
(0-25 ug/ml) was added in a total assay volume of 3.0 ml containing 
PBS, pH 7.4. The average molecular weight of D- and L-isomer was 
13,000 and 1,94,000 respectively. Control samples were prepared by 
taking equal amount of nDNA and polylysine separately. A l l assay tubes 
were vortexed gently and lef t for 30 min at room temperature. While 
recording the UV difference spectra of DNA-polylysine complex, nDNA 
in PBS (50 ug/ml) was taken as control . 
Preparation of DNA-Lysine Photoconjugate 
The photoconjugate was prepared by mixing calf thymus DNA 
with lysine (1:3 rat io, w/w) in PBS (0.01 M sodium phosphate, pH 7.4 
containing 0.15 M sodium chloride), pH 7.4 followed by overnight incubation 
at 4 °C. The mixture was irradiated under UV-A l ight (320-400 nm) 
for 30 min in nitrogen atmosphere and dialyzed wi th copious volume 
of 0.01 M carbonate-bicarbonate buffer, pH 10.7 to remove lysine molecules 
bound electrostat ical ly to phosphate of DNA backbone. The photoadduct 
was f inal ly dialyzed against PBS and photobound lysine was estimated 
by ninhydrin reagent (Moore and Stein, 1954). 
Preparation of DNA-Furocoumarin Photoadducts 
DNA in TNE buffer (0.01 M Tris, 0.05 M NaCl, O.OOOi^ M EDTA, 
pH 7.6) was mixed wi th psoralen and 8-methoxypsoralen in the rat io 
of 3.2:1 (vj/vj, DNA:drug). The mixture kept in dark at room temperature 
['fl] 
for ^ hr was irradiated for 30 min under 365 nm ultraviolet l ight. Tiie 
irradiated samples were extensively dialyzed against 0.01 M plnosphate 
buffer, pH 6.8. Finally, the photoadduct was characterized by UV absorption 
spectroscopy, thermal denaturation and fluorescence measurements. 
DNA Modification by Hydroxy! Radical 
The metal ions in DNA solution were chelated by pre-treatment 
wi th EDTA for 3 hr at room temperature at a f inal concentration of 
Im mol dm in phosphate buffer, pH IM (Blakely et a l . , 1990). Assay 
tube containing mixtures of DNA (1515 um bp), ferrous ions (525 um) 
and hydrogen peroxide (3030 uM) were incubated for 30 min at room 
temperature in 0.01 M phosphate buffer, pH 1 A. Deionized DNA wi th 
hydrogen peroxide and ferrous ions separately served as controls. A t 
the end of incubation, reaction products were dialyzed exhaustively 
against PBS and their UV absorption characteristics were recorded on 
Shimadzu UV-Z'fO spectrophotometer. 
Alkaline Sucrose Density Gradient Centrifugation 
The damage to DNA by hydroxyl radical was analyzed by alkaline 
sucrose gradient centr i fugat ion. Native and modified DNA samples (0.1 
ml each) were layered separately on top of a ^.8 ml linear 5-20 percent 
alkaline sucrose gradient containing 0.8 M sodium chloride, 0.2 M NaOH, 
0.01 M EDTA and 0.015 M p-aminosalicylate at pH 12.5 (Fujiwara et 
al . , 1977). The samples were centrifuged at 30000 rpm for 1 hr at 20 
°C in an SW 50.1 rotor of a Beekman ultracentr i fuge. Af ter centr i fugat ion, 
the bottom of the tubes were pierced wi th a needle and contents were 
fract ionated by drop collection {^.1 ml each). The absorbance of collected 
fractions was monitored at 260 nm. 
Absorption-Temperature Scan 
Native and modified DNA samples were subjected to heat denaturation 
by an electronically controlled heating device. The cuvette temperature 
was raised from 30 to 95 °C at a rate of 1 °C/min after ten min 
['*2] 
equilibration at 30 °C, The change in absorbance at 260 nnn was recorded 
with increasing temperature. The helix-coil transition temperature (Tm) 
was determined from percent denaturation data which was calculated 
as follows: 
Percent denaturation - x 100 
Ap - A30 
Where, 
Ay is the sample absorbance at various temperatures. 
Ar- is the final absorbance at 95 °C. F 
A,^ is the absorbance prior to heating. 
The change in melting temperature ( A T ) was calculated using the 
formula: 
A T = Tm^  - T ^  
m "> m 
w/u' xC and T S are the melting temperatures of native and modified 
where, I p-i m b r 
DNA sample respectively. 
DEAE Sephadex A-50 Column Chromatography 
Native and modified DNA samples were mixed separately with 
perchloric acid (70%) in a stoppered tube and boiled for one hr to release 
the bases. The sample, after neutralization, was placed on top of a 
DEAE Sephadex A-50 column (1.6 cm x "^^ cm) equilibrated with Tris-
HCl buffer, pH 7.2. The elution was carried out with the same buffer 
at a flow rate of 'fO ml/hr. Fractions (2.5 ml) were collected and monitored 
at 260 nm. Mixtures of equimolar concentration of bases (A, G, C, T) 
were also passed to locate the elution pattern of unmodified bases. 
Native and modified bases were identified on the basis of their unique 
absorption profile (Hasan and Ali, 1990). The extent of base modification 
was calculated by measuring the peak area. 
Measurement of Antibody Affinity 
One hundred microgram of immune IgG was incubated, in Ependorff 
tubes, with varying amount of DNA antigen in an assay volume of 0.2 
[^ ^3] 
mj. The controJ experiment was carried out with the same amount of 
antigens and preimmune IgG. The contents were vortexed and incubated 
for 2 hr at 37 °C and overnight at k °C. The soluble antigen- antibody 
complex was precipitated by adding cold saturated ammonium sulphate. 
The assay tubes were spun in microfuge at 8,000 rpm for 2.5 min and 
supernatant was careful ly removed. The unbound antigen was estimated 
by Hoechst dye 33258 and diphenylamine reagent. The binding data were 
analyzed and antibody af f in i ty was calculated (Langmuir, 1918). 
Immunization Scheme 
(a) Antibodies against normal human IgG 
Female rabbits (8-12 months old, weighing 1.0 to 1.5 kg) were 
immunized intramuscularly, in hind limbs, wi th freshly prepared emulsion 
of purif ied IgG (0.5 ml of 200 ug/ml in PBS, pH 7A) in Freunds' complete 
adjuvant in a total volume of 1.0 ml. Blood was collected from rabbit 
by cardiac puncture prior to immunization. Similar injections, but wi th 
incomplete Freunds' adjuvant, were given at weekly intervals for f ive 
weeks. Anti-IgG act iv i ty was evaluated in the immune serum collected 
after one week of the last injection. 
(b) Antibodies against DNA modified by hydroxy] radical 
Female rabbits were immunized wi th radical modified DNA as 
described earlier (Hasan and A l i , 1990). The immunizing antigen (100 
ug) was mixed wi th MBSA (1:1 rat io, w/w) and emulsif ied wi th equal 
volume of Freunds' complete adjuvant for f i rst inject ion. Subsequent 
injections were given in incomplete adjuvant. A single animal received 
a totaJ of 600 ug antigen in the course of six injections. Antibody act iv i ty 
was checked in the immune serum. Preimmune and immune sera were 
collected from the rabbit by cardiac puncture. 
[f'f] 
Immunoaffinity Purification of Antibodies 
(a) CNBr activation of Sepharose f^B 
Fifteen ml of supplied Sepharose 4B was suspended in dist i l led 
water, f i l tered and washed with 300 nnl of cold disti l led water on a 
sintered glass funnel (porosity G-2). Moist gel (about 10 g) in 10 ml 
of sodium carbonate was kept in ice-NaCl bath placed on magnetic 
st irrer. One gram cyanogen bromide in 0.8 ml acetonitr i le was slowly 
added to the gel w i th gentle st i r r ing. A f te r 12 min, the reaction product 
was f i l tered on sintered glass funnel washed with 'fOO ml of cold 0.01 M 
sodium bicarbonate and resuspended in 10 ml of the same buffer. The 
unreacted CNBr (drained eff luent) was reacted wi th ferrous sulphate 
to convert it into harmless ferrocyanide. A l l steps were carried out 
in a fume-hood chamber (A l l , 198'i). 
(b) PoIy-L-lysine coupling to activated Sepharose 'JB 
The method described by Wllchek (1973) was fol lowed. Immediately 
after CNBr act ivat ion of gel, equal volume of poly-L-lysine (100 mg 
in 10 ml of 0.1 M sodium bicarbonate) was added and kept at ^ °C 
for 12 hr wi th slow st i rr ing. The buffer was drained out and the gel 
was washed successively with 100 ml each of cold (i) disti l led water 
(ii) 0.1 N HCl (i i i) 0.1 M sodium bicarbonate and (iv) dist i l led water t i l l 
neutral. Finally the gel was suspended in UO ml of 0.15 M acetate buffer, 
pH ^.5. The extent of poly-L-lysine depletion due to covalent coupling 
with activated Sepharose ^B was quantif ied by the treatment of drained 
eff luent wi th TNBS as described by Habeeb (1966). 
(c) Immunoaffinity purification of anti-DNA antibodies 
DNA -[Polylysyl -Sepharose ^B] a f f in i ty column was prepared 
according to method described earlier (Nicotra et a l . , 1982) wi th l i t t l e 
modif icat ion. Twenty ml of polylys yl-Sepharose ifB was packed in a 
glass minicolumn (1.6 cm X 5 cm) and equilibrated with acetate buffer. 
Purif ied DNA (12.5 ml of 100 ug/ml in acetate buffer) was loaded onto 
the gel and unbound material was washed with 50 ml of PBS, pH 7A. 
1^5] 
Heat decomplemented SLE serum previously dialyzed against PBS was 
diluted 1:10 and passed through the colun^in. The unbound antibodies 
were washed and bound proteins were eluted with linear ionic strength 
gradient of 0.15-3.0 M sodium chloride in 0.01 M phosphate buffer, pi I 
7A. Fallthrough material was collected and monitored at 251 nm, 26C 
nm, 278 nm and 280 nm. The molar concentration of sodium chloride 
in fractions was evaluated by conductance measurements. 
(d) Regeneration of affinity column 
The same column was regenerated several times by washing 
succesively with 50 ml each of the foliowings: (i) distilled water (ii) 
0.1 N HCl (iii) 0.1 M sodium bicarbonate (iv) distilled water till neutral. 
Gel Electrophoresis 
(a) Polyacrylamide slab gel electrophoresis for proteins 
Polyacrylamide slab gel electrophoresis was performed under denaturing 
conditions as described by Laemmli (1970). The following stock solutions 
were prepared: 
(i) Acrylamide-bisacrylamide (30:0.8) 
Thirty gram acrylamide and 0.8 g bis-acrylamide was dissolved 
in a total final volume of 100 ml. The solution was mixed thoroughly, 
filtered and stored at ^ "C in amber color bottle. 
(ii) Resolving buffer : 3 M Tris-HCl, pH 8.8 
A stock solution was prepared by dissolving 36.3 g Tris base in 
^^ 8.0 ml of 1 N HCl. The contents were mixed properly, pH adjusted 
to 8.8 and the final volume brought to 100 ml. 
(iii) Stacking gel buffer : 0.5 M Tris-HCl, pH 6.8 
6.05 g Tris base was dissolved in 40 ml distilled water t i trated 
to pH 6.8 with IN HCl and the volume adjusted to 100 ml with distilled 
water. 
[t6] 
(iv) Electrode buffer : 0.025 M Tris, 
0.192 M glycine, 
0 .1% SDS 
pH 8.3 
(v) Sample buffer 
Six gm Tris was dissolved in 80 ml disti l led water and pH adjusted 
to 6.8 wi th O-phosphoric acid. The volume v/as made to 100 mi with 
disti l led water. To 12.5 ml of above solution was added 1 mg bromophenol 
blue and 12.5 ml glycerol. The contents were mixed thoroughly prior 
to use. 
(b) PAGE procedure 
The glass plates (19 cm x 16 cm) were soaked in chromic acid 
and thoroughly washed with tap water followed by one rinse wi th dist i l led 
water and ethanoi. Finally the plate was cleaned with tissue paper soaked 
m acetone, air dried and sealed with 1% agarose. The glass plates were 
separated by 1.5 mm thick spacer. 7.5% separating gel was layered 
with 2.5% stacking gel according to recipe given below (all volumes 
are in ml). 
Solution Resolving gel Stacking gel 
Acrylamide-bisacrylamide 7.5 2.5 
Resolving buffer 3.75 
Stacking gel buffer - 5.0 
10% SDS 0.3 0.2 
Disti l led water 16.95 11.3 
1.5% Ammonium persulphate 0.025 0.05 
The reagents were mixed and poured between glass plates. The 
gel was allowed to harden at room temperature. Protein samples 
(10-20 ug) in 0.01 M phosphate buffer, pH 7A were mixed wi th sample 
buffer in the rat io of ^:1 (w/w). SDS was added to a final concentration 
of 2% and protein sample was boiled for 5 min prior to loading. The 
electronhoresis was carried out for 6-8 hr at room temperature ?t 70 
[47] 
Volts. The gel was stained overnight in 0.0.5% Coo massie Bri l l iant 
Blue (R 250) nnixed wi th 25% iso-propyl alcohol and 10% glacial acetic 
acid. Destaining was carried out in a mixture of 10% acetic acid and 
10% methanol. 
(c) DNA electrophoresis on polyacrylamide gel 
DNA electrophoresis was carried out fol lowing the procedure 
ot Sealey and Southern (198.5). The fol lowing buffers were prepared 
for DNA gel electrophoresis: 
(i) U0% acrylamide in disti l led water 
(ii) 2% bisacrylamide in disti l led water 
(ui) Resolving gel buffer : 0.9 M Tris-borate, pH 8.3 containing 0.025 
M EDTA 
(iv) Electrode buffer : 0.09 M Tris-borate, pH 8.3 containing 0.0025 
M EDTA 
Recipe for 7.5% DNA-PAGE (all volumes in ml) 
Solution Resolving gel Stacking gel 
W% Acryamide 
2% bisacrylamide 
Gel buffer 
Disti l led water 
Ammonium persulphate 
TEMED 
The DNA sample (0.5-1.0 ug) was mixed wi th one-tenth volume 
of dye (30% Ficol l , 0.025% xylene cyanole FF in gel buffer) and electro-
phoresed for 6-8 hr at 70 Volts. The gel was stained with ethidium bromide 
(1 ug/ml) for 3U-4G min & DNA bands were visualized under UV l ight. 
(d) Agarose gel electrophorisis of DNA 
Thirty ml of 1% agarose NA dissolved in electrophoresis buffer 
(O.O'^  M Tris-acetate, pH 8.0 containing 0.002 M EDTA) was poured 
on horizontal gel tray (sealed from both the sides) and allowed to harden 
for 30-60 min at room temperature. The DNA samples, prepared as 
7.5 
7.5 
i^.O 
21.0 
50 mg 
0.025 
1.25 
1.25 
1.0 
6.5 
15 mg 
0.010 
['fS] 
described earlier, were put into the wells and eiectrophoresed for 2-
^ hr at 30 mA current in tank f i l led wi th the sanne buffer. 
(e) Gel retardation assay 
The antibody binding to DNA antigens was analyzed by altered 
electrophoretic migrat ion. Mixtures of 0.1 ug of B-DNA fragnnents (average 
size 200 bp) and varying amounts of IgG (50-250 ug) isolated from SLE 
serum were incubated in a total volume of 20-30 ul of 0.01 M sodium 
phosphate buffer, pH 7 A containing 0.15 M sodium chloride for 1-
4 hr at 'f °C. In case of DNA-RNA hybrid, 0.5 ug polymer was incubated 
with varying amounts of SLE IgG (25-100 ug). A t the end of incubation, 
2 ul dye solution was added to each assay tube. The complex was eiectro-
phoresed on polyacrylamide or agarose gel using Tris-acetate EDTA 
(pH 8.0) buffer at room temperature. On completion of electrophoresis, 
gels were stained and photographed under UV i l luminat ion. Control assays 
were carried out in the presence or absence of normal human IgG and 
ant i-DNA psoralen crosslink IgG that has been shown to be non-reactive 
towards native DNA (Hasan et a l . , 1991). 
Immunological Detection of Antibodies 
Immunized rabbit sera and SLE sera were tested for antibodies 
by immunodiffusion, counterimmunoelectrophoresis, and enzyme-linked 
immunosorbent assay, 
(a) Immunodiffusion (ID) 
ID was carried out by Ouchterlony diffusion system using glass 
petri dishes. Six ml of 0.^ percent molten agarose in PBS (pH 7A) containing 
0.1 percent sodium azide was poured onto glass petri dishes and allowed 
to solidify at room temperature. Wells, each 5 mm in diameter and 
separated by 8 mm distance were cut into liardened agarose gel. Appropriate 
concentration of antibody and antigen was placed in the wells and petri 
dishes were allowed to stand in moist chamber at room temperature 
for ^^8-72 hr. The gels were v/ashed with 5% sodium-citrate for two 
[ W ] 
hr to remove non-specific precipit in lines. The result was analyzed visually 
and photographed. 
(b) Counterimmunoelectrophoresis (CIE) 
CIE was performed according to the procedure described by Kurata 
and Tan (1976) with part ial modif icat ion. Molten agarose (0.6%) in l"!) 
mM barbital buffer, pH ZM containing 0 .1% sodium azide was poured 
onto 2.5 mm thick glass slides (2.5 cm x 7.5 cm) and allowed to harden 
at room temperature. The slides were stored at k "C and used within 
a week. The wells, 3 mm in diameter, were cut on the slides at a distance 
of 5 mm between the two opposite wells. Antigen (nucleic acid or protein 
in PBS, pH 1M) was placed in cathodal well and antibodies (immune 
sera or IgG) in the anodal wel l . Electrophoresis was performed for 30 
min in 50 mM barbital buffer, pH %M with a current of 3-'f mA per 
slide. Non-specific precipit in lines were removed by treatment with 
5% sodium-citrate solution. 
(c) Enzyme-linked immunosorbent assay (ELISA) 
(i) Buffers and substrate 
Tris buffer saline (TBS) : 
Tris buffer saline Tween-20 
(TBS-T) 
Bicarbonate buffer 
0.01 M Tris, 
0.15 M NaCl, 
pH lA 
0.02 M Tris 
0.14^ M NaCl , 
0.00268 M KCl , 
pH 7.4 containing 
500 ul Tween-20 
0.015 M sodium 
carbonate, 0.035 M Na-
bicarbonate, pH 9.6 
containing 0.002 M 
magnesium chloride. 
[50] 
Substrate 500 ug p-nitrophenyl 
phosphate per ml of 
bicarbonate buffer 
(ii) Assay procedure 
Polystyrene wells v/ere precoated with 100 ul of polylysine (50 
ug/ml in water) for ^3 min at room temperature. The wells were emptied 
and washed thrice with TBS. Hundred ul nucleic acid antigens (2.5 ug/ml 
in TBS) were coated and incubated for 2 hr at room temperature followed 
by overnight incubation at 'f °C. The protein antigen was coated at 
50 ug/ml in 0.05 M carbonate buffer (pH 9.6) without polylysine treatment 
of the wells. Next morning antigen coated v/ells were emptied and washed 
four times with TBS-T. Hundred ul of poly-L-glutamate were added 
to the antigen wells and washed after 2 hr. This was followed by 0.15 
ml of BSA (1.5% in TBS) coating for 2-6 hr to saturate the binding 
sites. Antibody to be tested, diluted in 1% TBS-BSA was added to antigen 
coated and control wells for 2 hr at room temperature and overnight 
at k °C. After adding appropriate alkaline phosphatase conjugate, color 
was developed with p-nitrophenyl phosphate. Absorbance measurements 
(at ^10 nm) were determined directly from microtiter plates with a 
Dynatech MR 600 reader. 
(iii) Competition ELISA 
The antigen binding specificity of antibody was defined by competition 
-inhibition experiments. For the assay, varying concentration of soluble 
competitors were incubated with antibody (serum or purified IgG). The 
mixture was incubated at room temperature for 2 hr and overnight 
at ^ °C, Inhibition of antibody binding in presence of various competitors 
was determined by measuring their ability to reduce the resulting absorbance 
relative to control assays lacking competitor. Each serum dilution or 
competitor was tested in duplicate. The rosult of inhibition were expressed 
as percent inhibition. 
[51] 
Induction in Rabbits of Antibodies Againsi Normal Human IgG 
Rabbits immunized wi th normal human IgG produced precipi tat ing 
antibodies. The antibodies were characterized by counterimmunoeJectro-
phoresis (CIE), iminunodil'Iusion (ID) and solid phase enzyme immunoassay 
(SPEIA). The antibody t i ter was found to be 1:16 by Ouchterlony double 
diffusion in agarose gel (Fig. 2a). The specif icity of antigen-antibody 
reaction was ascertained by immuno-crossreactivity of induced antibodies 
with immunogen, preimmune rabbit IgG and serum albumin (Fig. 2b). 
The results showed react iv i ty with immunogen but nonreactivity towards 
preimmune IgG and serum albumin. ELISA of immune serum on poly-
styrene plate coated wi th normal human IgG showed a t i te r of > 1:6^00. 
The binding of preimmune serum was of very low magnitude (Fig. 3). 
Double Strandedness of Native DNA 
Purif ied calf thymus DNA was characterized for double strandedness 
by physico-chemical methods. Agarose gel electrophoresis of DNA (1 u g) 
digested wi th nuclease SI (20 l.U.) showed identical mobil i ty and f luore-
scence on staining with ethidium bromide in comparision to native DNA 
(data not given). By contrast, heat denatured DNA incubated under identical 
conditions was completely digested by the enzyme. The double strandedness 
ol puri f ied DNA was further investigated by chromatography on hydroxy-
apatite. The hydroxyapatite bind both single and double stranded DNA 
molecules which are eluted at di f ferent ionic strength. The elution of 
purif ied DNA as a single peak at 0.25 M Pi is suggestive of its double 
strandedness. Purif ied DNA was also characterized by thermal denaturation. 
Thermal denaturation of native DNA showed no signif icant change in 
absorbance upto 80 °C. A sharp melting prof i le (Tm = 87.5 °C) (Fig. ^) 
reiterated the double strandedness of native DNA. 
[52] 
(a) (b) 
Fig.2(a). Evaluation of titer of anti-human IgG antibodies by Ouchterlony 
immunodiffusion. The central well (C) contained immunogen 
and peripheral wells \,2,3,k,5 and 6 represents neat, 1:2, 
1:^, 1:8, 1:16 and 1:32 dilution of antiserum. 
(b). Immunocrossreactivity of rabbit anti-normial human IgG. 
The central well (C) contained anti-human IgG whereas 
peripheral wells 1,2 and 3 represents immunogen, preimmune 
rabbit IgG and bovine serum albumin respectively. 
[53] 
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[55] 
Detection of Anti-Nucleic Acid Antibodies in SLE Sera 
The direct binding of SLE antibodies to native DNA was determined 
by ELISA. Table 2 shows the titer of serum antibodies investigated 
during the course of this study. Further studies were carried out on 
the sera which had elevated levels of anti-dsDNA antibodies, a marker 
antibody for the diagnosis of SLE. 
Fractionation of Serum Immunoglobulins 
Serum samples (control or SLE) after precipitation with fifty 
percent saturated ammonium sulphate were dialyzed extensively against 
0.05 M Tris-HCl, pH 8.0 containing 0.15 M sodium chloride and fractionated 
on Sephadex G 200 column. The fractions were read at 280 nm. Two 
well resolved protein peaks were identified (Fig. 5). Their absorbance 
was monitored at 278 and 251 nm in order to identify IgG peak. Fractions 
from 35 - ^3 were taken as IgG as their absorbance ratio (278/251) 
was 2.5. 
Characterization of Normal Human and SLE IgG 
Only antibodies of the IgG class were studied since it has been 
found that several cross reactions of anti-DNA antibodies are mainly 
associated with IgM antibodies of low avidity. Moreover, they are not 
the true representatives of the pathogenic anti-DNA antibodies found 
in SLE patients (Edberg and Taylor, 1986). 
The DEAE Sephacel purified IgG from control and SLE sera were 
found to be nearly free from contamination by other classes of immuno-
globulins as judged by their homogeneous movement in SDS-PAGE under 
non-reducing conditions. Purity of the isolated IgG was also characterized 
by ultraviolet absorption measurement at 251 and 278 nm. The absorbance 
ratio (278/251) was found to be constant for one class of immunoglobulins 
derived from rabbit, human and goat. It has been reported that mammalian 
IgG absorbance at 278 nm is about 2.5 - 3.0 higher than at 251 nm, 
in contrast to other serum proteins wheie this ratio is about 1 - 1.5. 
[56] 
TABLE 2 
Direct Binding of Anti-DNA Autoantibodies to Calf Thymus Double Stranded DNA 
_ 
SLE Serum Reciprocal of Antibody Titer 
1 200 
2 800 
3 100 
^ 1600 
5 ^00 
6 3200 
7 200 
8 6^00 
9 6400 
10 1600 
11 1600 
12 102400 
13 3200 
14 200 
\5 1600 
16 3200 
17 3200 
18 12800 
19 6400 
20 3200 
21 3200 
22 3200 
23 3200 
24 6400 
25 800 
26 1600 
27 3200 
Name of SLE patients from v/hum the sera were derived have 
been changed into numbers. 
[57] 
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Fig.5. Fractionation of SLE serum immunoglobulins 
on Sephadex G 200. F i f ty percent saturated 
ammonium sulphate precipitated serum proteins 
were loaded onto the column. Fractions were 
collected and monitored at 280 nm (—0— ) and 
absorbance ratio (278/251) (—»—) was evaluated. 
Fractions f rom 35-^3 were taken as IgG. 
[58] 
Measurements of absorbance at these two wavelengths may therefore 
indicate the fraction(s) containing IgG. Table 3 represents the absorbance 
values recorded for material isolated from one of the SLE sera. Similar 
values v.'ere obtained for normal human IgG. Every fresh batch of IgG 
was tested for purity before further investigations. 
Isolation of DNA Fragments 
Small DNA fragments were prepared by controlled digestion of 
native calf thymus DNA with micrococcal nuclease. The digested samples 
were passed through a Sepharose kb column. The fallthrough fractions 
were collected and monitored for DNA content at 260 nm (Fig. 6). 
Sizie of the DNA fragments was analyzed on non-denaturing polyacrylamide 
gel using Lambda DNA digest of EcoR I and Hind III. The average size 
of the fragments was in the range of ^100 to 600 base pairs (Fig. 6 inset). 
The fragments behaved as double stranded molecules on thermal denatura-
tion. 
Tm Dependence on Fragment Size 
The DNA fragments of varying size were melted by an electronically 
controlled heating device. The denaturation data were replotted to deter-
mine the helix-coil transition temperature (Tm) (Fig. 7). The Tm of 
the fragments was found to vary with size. The data presented in Table ^ 
can most simply be interpreted as inter- fragment variation of (G+C) 
and (A+T) residue. The fragments rich in G+C content will resist heating 
as compared to A+T rich fragments which denature early in the transition. 
Human Anti-Native DNA Autoantibody Binding to B-DNA 
B-conformation specific antibodies from human SLE serum were 
isolated on affinity column of DNA-[polylysyi~Sepharose ^B]. The SLE 
serum was diluted 1:10 in PBS and passed through the column. After 
application of linear sodium chloride gradient, the bound material eluted 
in three peaks (Fig. 8). Colorimetric estimation and ultraviolet measure-
[59] 
TABLE 3 
13 
14 
15 
16 
17 
18 
19 
20 
Ultraviolet Absorption Characteristics of SLE IgG 
Fraction Absorbance at Absorbance ratio 
Number 278/251 
251 nm 278 nm 
The IgG was fractionated on DEAE Sephacel matrix . 
0.200 
0.193 
0.153 
0.23^1 
0.161 
0.078 
0.065 
0.061 
0.428 
0.485 
0.358 
0.523 
0.315 
0.164 
0.128 
0.122 
2.14 
2.51 
2.33 
2.23 
1.95 
2.10 
1.96 
2.00 
[60] 
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DNA digested with micrococcaJ nuclease. Four ml fractions 
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[62] 
TABLE 4 
Melting Temperature and Percent Hyperchromicity of DNA Fragments 
Native DNA 
fragments 
(average 
size) 
300 bp 
175 bp 
90 bp 
70 bp 
Percent 
duplex 
melted at 
80 OC 
10 
12 
39 
55 
Percent 
chromic! 
at 
95 OC 
29.8 
40.1 
35.0 
31.0 
hyper-
ty 
Melting 
tempera-
ture (Tm), 
86.0 
85.0 
80.5 
79.5 
[63] 
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[6'f] 
ments revealed proteins in peak 1 and peak 2 and DNA in peak 3. Tine 
absorbance ratio of peak I (278/251) was found to be 2.62 typical of 
mammalian IgG. Ouchterlony immunodiffusion of peak fractions wi t l i 
anti-human IgG showed precipit in line of complete identi ty wi th peak 
1 and non-reactivity with materials from peak 2 and peak 3 (Fig. 8 
ifisct). This inturn sliows that protein in peak I is a homogeneous population 
of IgG recognizing the native B-conformation of DNA. 
SLE Anti-DNA Antibodies Recognize DNA-Lysine Photoadduct 
Native calf thymus DNA covalently modified wi th lysine under 
UV-A light (320-^00 nm) was shown to bind naturally occurring ant i -DNA 
antibodies from human SLE sera (Alam et a l . , 1992). By the photoaddition 
of one lysine molecule per helical turn of DNA (unpublished data), the 
native B-conformation was considerably altered. The altered molecule 
dif fer ing from average B-helix geometry has been found to be immunogenic 
in contrast to native DNA. 
Direct binding of SLE ant i-DNA antibodies to chemically modified 
and photomodified DNA antigens has been presented in Table 3. Besides 
nDNA, the naturally occurring antibodies indicated appreciable binding 
with Z-DNA and DNA-lysine photoadduct. In another set of experiments 
it was found that seventy percent of the SLE sera recognized DNA-
lysine photoadduct better than native DNA adsorbed direct ly on the 
polystyrene plate (Fig. 9). The binding pattern of SLE autoantibodies 
upto 1:3200 dilution with either of the antigens was similar to those 
observed at lower dilution (1:100 dilution). In competi t ive binding experi-
ments anti-dsDNA IgG isolated from af f in i ty matr ix of native DNA-
[polylysyl-Sepharose '>B] showed maximum af f in i ty towards DNA-lysine 
photoadduct followed closely by nDNA based on the amount of competitor 
required for 50 percent inhibit ion (Table 6). 
Human Anti-DNA Autoantibody Binding to A-, B-, and Z-DNA 
Serum antibodies from SLE exhibited a broad spectrum of antigen 
recognition as demonstrated by their abi l i ty to recognize a variety of 
nucleic acid antigens presenting altogether divergent conformations (Alam 
[65] 
TABLE 5 
Binding Characteristics of Naturally Occurring Autoantibodies with Native 
and Modified Nucleic Acids 
Antigen Reciprocal of antibody t i ter 
nDNA \02W0 
DNA-lysine photoadduct 51200 
Z-DNA 12800 
ssDNA 3200 
DNA complexed with cobalt hexaammine 1600 
Poly(dG-dC)-psoralen photoadduct 800 
DNA intercalated with ethidium bromide ^00 
[66] 
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Fig.9 Binding of human SLE antibodies to native DNA ( | ) and DNA-lysine photoconjugate 
( D )• The binding of control serum with either of the antigens was negligible. 
[67] 
TABLE 6 
Relative Binding Profile of Anti-DIMA IgG 
Comp)etitor 
Competitor 
concentration 
for 50% in-
hibition (ug/ml) 
7.5 
5.5 
38.0 
-
Maximum 
percent 
inhibition 
at 50 ug/ml 
97 
91 
55 
39 
21^ 
nDNA 
DNA-Iysine photoadduct 
ssDNA 
nDNA UV-irradiated 
F^NA 
[68] 
and AJi, 1992). Direct binding ELI5A un polystyrene plates coated with 
native calf thymus DNA indicated high binding (titer>l:6^00) with different 
dilutions of a typical SLE serum (Fig. 10). While nDNA proved to be 
an effective inhibitor of DNA-anti-DNA antibody interaction, RNA (buffalo 
thymus) and single stranded DNA showed inhibition at higher competitor 
concentration (Fig. 11). Competition ELISA with Z-form of poiy(dG-me dC). 
poly(dG-me dC) and high salt brominated calf thymus DNA showed appre-
ciable inhibition in antibody activity (Fig. 12). The latter polymer has 
been shown to attain Z- or analogous conformation on bromination in 
high salt (Hasan and Ali, 1990). However, poly(dG-dC).poly(dG-dC) in 
low salt (B-conformation) showed inhibition similar to nDNA. With former 
the maximum inhibition attained was 81 percent and 50 percent inhibition 
obtained with only 1.1 ug of inhibitor (Table 7). Autoantibody recognition 
of poly(rG).poly(dC), a polymer known to be present in A- or analogous 
conformation, resulted in 77 percent elimination of antibody activity 
with 10 ug of inhibitor (Fig. 12). 
Competition Studies by Polynucleotides 
Besides native DNA, certain right handed helical double-stranded 
polydeoxyribonucleotides which differ slightly from the average B-DNA 
helix were also employed as inhibitors of nDNA-autoantibody interaction. 
It was found that the epitope recognition of polymers by the antibody 
was of varying degree (Fig. 13). 
Gel Retardation Assay 
Antibody binding to polynucleotide was studied in poiyacrylamide 
and agarose gel. When mixtures of SLE anti-DNA IgG and DNA fragments 
(average size 200 bp) were subjected to slab gel electrophoresis under 
non-denaturing conditions, the antigen-antibody complexes showed different 
degree of retarded mobility (Fig. l^a). With increasing concentration 
of antibody the amount of immune complexes, as judged by their fluore-
scence intensity, was found increased whereas the amount of unbound 
[69] 
E 
c 
o 
us 
< 
OD 
a: 
o 
CD 
< 
- LOG SERUM DILUTION 
Fig.lO. Assay of anti-DNA antibodies by ELISA. 
The polystyrene plate was coated with 
native DNA. Normal human serum (—O—) 
and SLE serum (-•—). 
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Fig. 11. Inhibition ELISA of SLE ant i-DNA antibodies. The competitors were 
native DNA (—O—), heat denatured DNA ( — • — ) and RNA (-•)(•—). 
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Fig.l2. Inhibition ELISA of SLE anti-])NA antibodies. The competitors were Br4 
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TABLE 7 
Inhibition of the Binding of Anti-DNA Autoantibodies 
by Polynucleotides 
Competitor 
nDNA 
Poly(dA-dU).poly(dA-dU) 
Poly(dG-dC).poly(dG-dC) 
Poly(dA-dG).po]y(dC-dT) 
ssDNA 
PoJy(dA).poJy(dT) 
Poly(rG).poly(dC) 
Poly(dG-me dC).poIy(dG-me dC) 
Br-DNA 
RNA 
Poly(dI-dC).poly(dI-dC) 
Poly(dG).poIy(dC) 
Poly(dC) 
PolyidG) 
Poly(U) 
Concentra 
tion for 
50% inhibi-
tion (ng/ml) 
0.38 
1.0 
1.1 
3.6 
3.8 
5.3 
3.2 
0.9 
9.5 
NIL 
NIL 
NIL 
NIL 
NIL 
NIL 
Maximum 
Percent 
Inhibition 
at 10 ug/ml 
77 
77 
81 
65 
63 
68 
77 
55 
•X-
85 
^^ 
39 
27 
35 
NIL 
NIL 
% Relative 
Affinity 
100 
38 
35 
I I 
10 
07 
12 
42 
04 
-
-
-
-
-
-
Inhibition at 100 ug/ml. 
[73] 
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Fig.l3. Competit ion ELISA with SLE ant i-DNA antibodies 
The coating antigen was native calf thymus DNA. 
The competitors were poly(dG).poly(dC) i--^-), poly(dA). 
poly(dT) (—•(>-—), po]y(dA-dG).poly(dC-dT) (—O—) and 
doube stranded: poly (dG-dC) ( — • — ), poIy(dl-dC) 
(-A-) and poly (dA-dU) (-A-). 
[7^] 
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(a) (b) 
Fig.l^(a). Binding of SLE IgG to B-DNA fragments as analyzed by gel retardation 
assay. B-DNA fragments (200 bp) (O.I ug) were incubated with buffer 
(lane I), 100 ug of normal human IgG (lane 2), 100 ug of anti-DNA-
psoralen crosslink IgG (lane 3) or various concentrations of SLE antibodies 
(50 ug, lane 5; 100 ug, lane 6; 130 ug, lane 7; 200 ug, lane 8; 250 
ug, lane 9) for I hr at 'i °C and eiectrophoresed on polyacrylamide 
gel (2.5% stacking on 7.5% separating). Lane k contained 100 ug 
of SLE IgG. 
(b). Binding of SLE IgG to poly (rG).poly(dC). The hybride (0.5 ug) was 
incubated with buffer (lane 1), 100 ug of normal human IgG (lane 
2) or various concentrations of SLE IgG (25 ug, lane 3; 50 ug, lane ^; 
75 ug, lane 5; 100 ug, lane 6) for I hr at ^ °C and eiectrophoresed 
on 1% agarose. 
[75] 
DNA fragments indicated proportional decrease in their concentration 
(Lanes 5 thru 9). Norn-ial human IgG and anti-DNA-psoraien crosslink 
IgCi (Hasan et a l . , 1991) showed no immune complex formation (lanes 2 
and 3) and were negative controls. 
The antibody binding to polY(rG).poly(dC) was also studied by 
agarose gel eletrophoresis (Fig. I'+b). In this case too, retardation in 
the mobil i ty of hybrid was observed as a consequence of immune comp-
lex(es) formation (lanes 3 to 6). The fluorescence was proportional to 
the size of iininune complex. Normal human IgG incubated under identical 
conditions did not show immune complex format ion. 
Binding of Anti-DNA Antibodies to DNA- Furocoumarin Photoadducts 
Psoralens (furocoumarins) are a class of compounds which can 
intercalate between base pairs of double stranded nucleic acids. Upon 
UV-A irradiat ion, the intercalated psoralens can photoreact prominently 
with pyrimidine bases to yield monoadducts as well as interstrand diadduct 
(Song and Tapley, 1979; Cimino et al . , 1985; Parsons, 1980). 
Furocoumarins modified native DNA preparations (after extensive 
dialysis) were characterized by UV, fluorescence and thermal denaturation 
studies. Al l these experiments suggested that furocoumarins were cova-
lently bound to pyrimidine bases of DNA forming diadducts (Hasan et al . , 
1991). Direct binding of 5LE autoantibodies to furocoumarin-DNA adducts 
has been shown in Fig. 15. The true recognition of PUVA modified 
DNA was evaluated by competi t ion-inhibit ion assay. The DNA-8-M0P 
photoadducts were ef fect ive inhibitors of nDNA-ant i -DNA IgG interactions 
(Table 8). The level of inhibition by DNA-psoralen and poly(dG-dC)-psoralen 
was ^3 and 38 percent respectively. 
Characteristics of Brominated Nucleic Acid Polymers 
The sodium chloride induced B — > Z transition in case of poly 
(dG-dC) can be measured by circular dichroism (Fig. 16 taken from Pohl 
and 3ovin, 1972) and ultraviolet absorbance spectroscopy (Pohl, 1983). 
The C D . spectra of poly(dG-dC) in high salt showed near inversion 
[76] 
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Fig.] 5. Direct binding assay of SLE antibodies. The 
polystyrene plate was coated with (a) native 
DNA (~^ — ) , poly(dA-dT)-8-MOP (—0— ) and 
poly(dG-dC)-psoralen ( — • — ) (b) native DNA 
(—•X-—), DNA-8-M0P (—0—) and DNA-psoralen 
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TABLE 8 
Inhibition of the Binding by DNA-Furocoumarin Photoadducts of SLE 
Anti-DNA IgG 
Comp>etitor 
Maximum percent 
inhibition 
nDNA 
n \A -8 -MOP 
76 
7S 
DNA-psoralen if9 
Poly(dA-dT)-8-MOP 77 
Poly(dG-dC)-psoralen 38 
at 50 ug/ml 
at 30 ug/ml 
[78] 
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Fig. 16. Circular dichroism spectra 
of poly(dG-dC).poly(dG-dC) in low 
( ) and high salt ( ) 
at pH 7.2. The low and high 
salt represent 0.15 M and U.O M 
sodium chloride in phosphate 
c i t rate buffer. Taken from 
Pahl and 3ovin, 1972. 
[79] 
with a positive band at 26^ nm and a negative band at 29k nm. Fig. 17 
siiows the ultraviolet right to left transit ion of poly(dG-dC) wi th apparent 
red shift in absorption spectrum. The change in UV absorption spectrum 
resulted in a change of absorbance ratio [{29^+296)/260] from 0.119 
in low salt to 0.322 in high salt (Table 9). The red shift observed for 
poly(dG-dC) in high salt has been explained by Pohl in 1971. He proposed 
that binding of cations to two adjacent base pairs can bring about the 
shift of absorption spectrum due to an ion-dipole interact ion. The u l t ra-
violet difference spectra of poIy(dG-dC) in if M sodium chloride showed 
positive band maxima at 259 and 29^ nm and minima at 2 *^0 nm (Fig. 18). 
Unlike poly(dCi-dC), DNA fragments in high salt did not show apparent 
red shift but hypochromic ef fect was clearly seen (Fig. 17). The UV 
difference spectra of DNA fragments showed positive band wi th absorbance 
maximum at 257 nm and minimum at 2W nm (Fig. 18). Native DNA 
under high salt conditions exhibited the similar UV and difference spectra. 
The high salt induced Z-DNA form of poly(dG-dC) and altered 
conformations of native DNA and DNA fragments of varying size was 
stabilized by bromination (Moller et al . , 198^). The bromine atoms 
have been shown to add predominantly to the C8 position of the guanine 
imidazole ring and less frequently to the C5 position of cytosine. The 
UV difference spectra of brominated 'Hily(dG-dC) form brought under 
low salt conditions exhibited a positive peak at 3100 nm. The negative 
band was found to be peaking at 238 - 283 nm (Fig.) 9). Fig. 19 inset (taken 
from Moller et al . , 198^ 1) shoves the C.D. spectra of brominated polymers 
with part ial ly converted ( 8 = 0.6) and ful ly converted Z-DNA ( 6= I). 
Although both polymers exhibit near inversion of C.D. spectra but part ial ly 
converted DNA showed bromination of 22% guanine and 8% cytosine 
residues and ful ly converted Z-DNA exhibited 38% guanine and 18% 
cytosine modif icat ion. The UV absorption spectra of native DNA fragments 
after bromination in low and high salt conditions showed loss in absorbance 
at 260 nm with a concomitant increase at 295 nm (Fig. 20a). The >smin 
was shifted from 230 nm to 2^0 nm (under low salt) and 2^5 nm (under 
high salt) respectively. The difference spectta of native DNA fragments 
after bromination in either low or high salt conditions (Fig. 20b) showed 
[801 
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Fig.17. UV absorption spectra of double stranded poly 
(dG-dC) in 0.15 M ( ) and if.O M NaCl 
( ) and DNA fragments (300 bp) in 0.15 M 
( ) and k.O M NaCl ( •) respectively. 
The spectra were recorded using buffer as control 
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TABLE 9 
The UV Absorbance Ratio of DNA Polymers Under Low and High Salt 
Conditions 
Polymers 
Sodium 
Chloride 
concen-
tration 
Absorbance ratio 
260/280 (29^+296)/260 
Poly(dG-dC).poly(dG-dC) 
Poly(dA-dG).poly(dC-dT) 
Native DNA 
Native DNA fragments: 
70 bp 
90 bp 
120 bp 
175 bp 
300 bp 
Poly(dG-dC).poly(dG-dC) 
Poly(dA-dG).po!y(dC-dT) 
Native DNA 
Native DNA fragments: 
70 bp 
90 bp 
120 bp 
175 bp 
300 bp 
0.15 M 
0.1.; M 
0.15 M 
0.15 M 
k M 
i4 M 
k M 
•^ M 
2.0^3 
1.865 
1.874 
1.381 
\Ak7 
1.502 
1.101 
1.^ 5^7 
1.520 
1.800 
1.836 
1.352 
l.'i32 
1.502 
1.378 
1.411 
0.1 19 
0.116 
0.113 
0.180 
0.151 
0.166 
0.166 
0.153 
0.322 
0.134 
0.114 
0.222 
0.180 
0.183 
0.195 
0.187 
[82] 
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Fig.18. UV difference spectra of poly(dG-dC) ( ) 
and DNA fragments in ^.0 M NaCI ( ). 
Respective polymer in 0.15 M NaCI served 
as corresponding control. 
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Fig.20(a), Ultraviolet absorption spectra of native and brominated DNA 
fragments. DNA fragments in 0.15 M sodium chloride ( ), 
fragments brominated in 0.15 M ( ) and 4.0 M sodium chloride 
(b). UV difference spectra of brominated polymer in low ( ) 
and high salt ( ) concentrations. Unbrominated DNA fragments 
served as control. 
[85] 
partial resemblance with difference spectra of high salt brominated 
poly(dG-dC). The positive band was found peaking around 306 nm and 
the negative band was found in between 238-288 nm (low salt brominated 
polymer) and 238-286 nm (high salt bromin.. icd polymer). Table 9 and 
10 summarizes the absorbance ratios for unbrominated and brominated 
polymers under low and high salt conditions including native DNA fragments 
of varying size. 
Effect of Polylysine on DNA Conformation 
The effect of polylysine addition on the native B-conformation 
was monitored by UV spectroscopy. After the addition of varying amounts 
of polylysine to DNA, the complex was mixed thoroughly and left at 
room temperature for I hr to attain equilibrium. The UV absorbance 
and difference spectra of polylysine-DNA complex was recorded by taking 
DNA as control. Effect of both D- and L-polylysine was evaluated to 
see if they can cause different levels of effect on native B-conformation 
under identical conditions. At low concentrations of poly-L-lysine there 
was little increase in absorbance at 260 nm while at around 300 nm 
absorbance was significantly higher (Fig, 21a). Also, the )>s min was shifted 
by 2 nm from 230 to 232 nm. When the concentration was raised to 
10 ug/ml the absorption spectra showed hyperchromicity at 260 nm and 
a further increase in absorbance at 300 nm. The ^v min was shifted 
towards higher wavelength by li nm. In UV absorption spectra, at 260 nm, 
the effect of poly-D-lysine on native DNA was similar to poly-L-lysine 
but the absorbance around 300 nm was higher for poly-D-lysine (Fig. 21b). 
At 10 ug/ml, the absorbance at 300 nm was 0.1'^ O and 0.190 for poly-
L-lysine and poly-D-lysine respectively. When polylysine concentration 
was further raised to 12.5 ug/ml the absorption spectra of D- and L-
forin were totally different (Fig. 22). At 12.5 ug, poly-L-lysine showed 
a decrease in absorbance at 260 nm and increased absorbance at 300 
nm. By contrast, poly-D-lysine at the same concentration caused hyper-
chromicity at 260 nm. The high absorbance at ^00 nm could arise as 
a result of turbidity in sample at high ligund concentration. 
To monitor any significant topological change in native conformation, 
[S5] 
TABLII 10 
The UV Absorbance Ratios of DNA Polymers Brominated Under Low 
and High Salt Conditions 
Polymers 
Sodii 
Chlo 
cone 
j m 
ride 
ent-
ration 
0.15 
0.13 
0.]'^ 
0.15 
it M 
ti M 
k M 
li M 
M 
M 
M 
M 
Absor 
260/280 
1.790 
1.9^ 9^ 
1.532 
2.382 
2.189 
2.337 
1.879 
2.111 
1.160 
1.529 
\A2\ 
1.650 
2.216 
1.901 
1.901 
1.6 *^8 
bance rat io 
(29'f+296)/260 
0.212 
0.203 
0.^36 
0.221 
0.217 
0.198 
0.311 
0.2i4it 
0.29^ 
O.'f'^l 
0.321 
0.380 
0.211 
0.295 
0.290 
0.379 
Poly(dG-dC).poly(dG-dC) 
Poly(dA-dG).poiy(dC-dT) 
Native DNA 
Native DNA fragments: 
70 bp 
90 bp 
120 bp 
175 bp 
300 bp 
PoJy(dG-dC).poly(dG-dC) 
Poly(dA-dG).poiy(dC-dT) 
Native DNA 
Native DNA fragments: 
70 bp 
90 bp 
120 bp 
175 bp 
300 bp 
[87] 
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Fig.21. IJV absorption spectra of native DNA in presence of (a) 2.5 ( ), 5.0 (-•-•) 
and 10 ug/mi ( ) of poly-L-lysine and (b) 2.5 (- ), 5.0 ( ^ and 10 ug/ml 
( ) oi poly-D-lysine.( ) represents the UV spectra of nacive DNA. 
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Fig.22. UV absorption spectra of native DNA in presence of (a) 12.5 ug/ml 
( ) poly-L-lysine and (b) 12.5 ug/ml of poly-D-lysine ( -). 
( ) represents the UV spectra of native DNA. 
[89] 
the absorbance ratios of 260/280 and average of (29^+296)/260 is a 
significant parameter. Table 1 ) summarizes the effect of polylysine 
concentrations on absorbance ratio. The effect of poiy-D-iysine seem 
to be more pronounced. Data analysis by absorbance ratios can give 
further insight into the changing DNA conformation as this parameter 
was independent of DNA concentrations. 
The UV difference spectra of polylysine-DNA complex was recorded 
to monitor change in secondary structure. Equal amount of DNA without 
polylysine served as control. At low concentrations of poly-L-lysine 
the positive peak at 280 nm was very shallow but as the concentration 
was raised the sharpness of the peak became more distinct (Fig. 23a), 
thereby indicating that native B-conformation is being perturbed by the 
added Ijgand and the molecule is heading towards a neoconformation. 
On the other hand poly-D-lysine showed a positive peak which showed 
maximum at 295 nm and a more steep negative band at 255 nm (Fig, 23b). 
Further increase in polylysine concentration gave birth to a new type 
of spectra which cannot be solely due to aggregation, if it is there 
at all (Fig. 2k). At 25 ug/ml of poly-D-lysine, the difference spectra 
exhibited a shallow positive peak at 300 nm and a large negative band 
at 248-280 nm. The UV difference of high salt brominated poly(dG-
dC) showed a positive peak at 300 nm and a negative band peaking 
between 238-283 nm. Although the high concentration of poly-D-lysine 
caused some turbidity (may be due to aggregation) in the solution but 
turbidity alone cannot bring about a gross structural change. The binding of 
SLE anti-dsDNA IgG to some of the simple amines have been shown 
in Table 12. 
Characterization of DNA Modified by Hydroxy] Radical 
It in an established fact that Fenton's reagent (hydrogen peroxide + 
ferrous ions) results in the production of hydroxyl radical (Floyd, 1981). 
The radical formation was evident by its ability of causing single strand 
breaks in supercoiled DNA. As a result, nicked circular form showed 
slow electrophoretic migration compared to fast migrating supercoiled 
[90] 
TABLE 11 
Effect of PolylysJne Addition on the UV Absorbance Characteristics 
of Native DNA 
L-isomer 
D-isomer 
Microgram 
polylysine 
Nil 
2.5 
5.0 
10.0 
12.5 
25.0 
Nil 
2.5 
5.0 
10.0 
12.5 
25.0 
260/280 
1.883 
1.805 
1.7^6 
1.635 
1.739 
I.^^O 
1.896 
1.83^ 
1.717 
1.557 
1.357 
1.089 
Absorbance ratio 
(29*+296)/260 
0.10^ 
0.12^ 
0.1if9 
0.209 
0.164 
0.320 
0.095 
0.119 
0.168 
0.259 
0.388 
0.737 
[91] 
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Fig.23. Ultraviolet difference spectra of polylysine-DN A complex, (a) 
at 2.5 ( ), 5.0 ( ^ and 10 ug/ml ( •) of L-polylysine 
and (b) at 2.5 ( ), 5.0 ( ) and 10 ug/ml ( ) of D-
polylysme. Native DNA without polylysine was taKen as control. 
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TABLE 12 
Inhibition of Binding by Amines of SLE Anti-DNA IgG to Native DNA 
Inhibitors Percent inhibition 
at 50 ug/ml 
Spermine 53 
Ethionine UU 
Agmatin Sulfate 32 
Tryptamine 26 
Histamine 24 
Tyramine 18 
Lysine NI 
Poly-D-Jysine Nl 
Poly-L-lysine NI 
Histone H^A NI 
Arginine NI 
Putrescine NI 
NI - No iniiibition 
m] 
form in agarose gel eJectrophoresis (Fig. 25). 
The ultraviolet absorption scan of modified DNA showed hypo-
chromici ty at 260 nm compared to native DNA under identical conditions 
(Fig. 26). That the DNA modified by hydroxyl radical did not loss its 
secondary structure is revealed by its desorption from hydroxyapatite 
in the molarity region of double stranded DNA (Fig. 27). Native DNA 
sedimentation in alkaline sucrose gradient showed a single sharp boundary 
of high molecular weight species. Treatment of hydroxyl radical modified 
DNA under identical conditions Vv'as found to loose the sharp boundary 
pattern and instead i t revealed a sedimentation prof i le quite dist inct 
from the one observed for nDNA (Fig. 28). The altered sedimentation 
profi le of modified DNA indicates that the single strand breaks are 
randomly situated which appeared as DNA fragments of varying size 
that sediment more slowly than the intact single strands of alkali denatured 
native DNA. Temperature controlled denaturation of native and modified 
DNA showed a significant decrease in melting temperature (Fig. 29). 
A 6.5 °C decrease of melt ing temperature could be at t r ibuted to the 
local helix distort ion caused by base modif ication and part ial unstacking. 
The physico-chemical characteristics of ative and modified duplex has 
been presented in Table 13. 
Native and modified DNA were analyzed on DEAE Sephadex A-50 
matrix after acid hydrolysis to separate and quantitate the modified 
bases. Column chromatography of modified DNA hydrolysate indicated 
RO> induced base modification (Table l'^). The relat ive susceptibil ity 
of DNA to modif ication by hydroxyl radical was as follows: 
Thymine >• Cytosine y Adenine = Guanine 
The immunogenicity of modified DNA v/as investigated in rabbits 
immunized wi th modified DNA complexed wi th Freunds' complete/incomplete 
adjuvant. Unlike native DNA, hydroxyl radical modified calf thymus 
DNA induced high t i ter antibodies. Preimmune serum showed negligible 
binding wi th immunogen. DEAE Sephacel purif ied immune IgG showed 
[95] 
Fig.25. Gel electrophoresis of supercoiled DNA 
in presence of Fentons' reagent. Lane 1, 
DNA; Lane 2, DNA + hydi i^ en peroxide; 
Lane 3, DNA + hydrogen peroxide + Fe^''"ions. 
[96] 
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Fig.26. Ultraviolet absorption spectra of native ( ) 
and hydroxyl radical modified DNA ( ). 
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Fig.27. Hydroxyapatite column chromatography of 
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TABLE 13 
Ultraviolet and Thermal Denaturation Characteristics of Native and 
Modified DNA Under Identical Experimental Conditions 
Parameter Native DNA Modified DNA 
Absorbance ratio (260/280) 
Percent hyperchromicity at 95 °C 
Melting temperature (Tm), °C 
Onset of duplex melt ing, °C 
2.20 
36.03 
89.0 
80.0 
1.95 
25.10 
82.5 
714.O 
[ l o t ] 
TABLE I'f 
Modification of Bases in DNA Exposed to Hydroxyl Radicals 
Base Modification (%) 
Adenine 30.05 
Guanine 29.20 
Cytosine 38.80 
Thymine ^9.25 
[102] 
high degree of binding with native DNA besides innmunogen (Fig, 30). 
Preimmune IgG as control showed negligible binding to these antigens. 
To ascertain the antibody specif ici ty, competit ion ELISA with immunogen 
and other double stranded nucleic acids were carried out. In compet i t ion-
inhibit ion assay, the induced antibody binding was f i f t y percent inhibited 
by the immunogen at a concentration of 0.32 u g/ml (Fig. 31a). The 
c ross- reac t iv i t y of induced antibodies wit l i B-c:onforiiiations like native 
DNA, poly(dA-dG).poly(dC-dT), poly(dA-dl )).poly(dA-dU) and poly(dl-dC). 
poly(dl-dC) was of varying strength (Fig. 31b). The immunogen-antibody 
interaction was also analyzed by precipitat ing the complex with saturated 
ammonium sulphate. The unbound antigen was estimated in the supernatant 
by diphenylamine reagent. Fig. 32 represents that at 50 U g of antigen 
concentration all the antibody binding sites were saturated and further 
increase in antigen concentration does not improve the binding. Almost 
f i f t y percent of the added antigen was bound by the anti-ROS-DNA 
antibodies. The induced antibody af f in i ty was evaluated from Langmuir 
-8 plot (Fig. 33). The antibody af f in i ty was computed to be 2.7x10 M. 
To probe the possible role of hydroxyl radical (or ROS in general) 
in the pathogenesis of SLE, four sera having di f ferent levels of ant i -
DNA autoantibodies were tested. Binding of these antibodies (at 1:100 
di lut ion of serum) wi th native and modified DMA has been depicted 
in Fig. 3'fa. The binding pattern of some of these autoantibodies upto 
1:6^00 dilution of serum with either of the antigens was similar to 
those observed at lower di lut ion. It was found that SLE autoantibodies 
recognit ion of modified DNA was better than native DNA under identical 
conditions. However, one serum sample (No. 1) showed high binding 
with native DNA as compared to modified DNA preparation. Compet i t ion-
inhibit ion assay of SLE autoantibodies with native and modified DNA 
as inhibitors have shown that ROS modi.icd DNA is a better inhibitor 
of autoantibody-nDNA interact ion. The amount of competitor required 
for 50 percent inhibit ion of autoantibody binding was found to be 
0.03 ug /ml and 0.13 ug/ml in case of modified DNA and nDNA respectively 
[103 ] 
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Fig.33- Determination of antibody af f in i ty by Langmuir 
plot. 
[ 1 0 7 ] 
o 
QD 
I 
2 
Z 
,_) 
a: 
( 1 
£ 
c 
o 
LU 
o 
z 
< 
CD 
cr 
o 
CD 
< 
1 2 3 4 
S L E SERUM SAMPLE 
MICROGRAM INHIBITOR 
Fig.3'f(a). Binding of human lupus antibodies to ROS-DNA ( | 
and native DNA ( D ). (b) Inhibition of autoantibody-
nDNA interaction by native DNA (—O— ) and ROS-DNA 
[108] 
(Fig. 34b). Similar results were obtained with otiner SLE serum samples. 
Antibody Detection of Z- or Analogous Conformations 
Chemical modification with different reagents has been extensively 
used as a tool to study the structure and function of nucleic acids in 
the free state or in nucleoprotein complexes. Antibodies with predefined 
specificity can be used as a yardstick to locate a particular conformation 
in a complex biological system such as mammalian genome. 
The poly(dG-dC) brominated under high salt conditions was found 
to attain Z-conformation. The monoclonal anti-Z-DNA antibody (Z 22) 
binding was nearly 80 percent inhibited at a Z-DNA concentration ot 
10 Ug/ml (Fig. 35). The fifty percent inhibition was seen at k.25 u g/ml 
of Z-DNA. This demonstrates that Z 22 is a highly specific probe for 
Z-DNA conformation. Z 22 recognition of native poly(dG-dC) or low 
salt brominated poly(dG-dC) was negligible. These antibodies were also 
used as tracer of Z- or Z-like epitopes appeared on poly(dA-dG).poly(dC-dT) 
brominated under 4 M and 0.15 M sodium chloride. The Z 22 binding 
to Z-DNA was inhibited to the extent of \k and 23 percent by high 
and low salt brominated poly(dA-dG).poly(dC.-dT) (Fig. 36). These type 
oi sequences are widely distributed in mammalian genome and have 
potentiality to undergo conformational transition besides formation oi 
multistranded structure when the pH of thi,- medium is lowered. 
The anti-dsDNA IgG derived from human lupus were also tested 
for their binding to poly(dA-dG).poly(dC-dT). it was found that with 
alteration in poly(dA-dG).poly(dC-dT) native conformation (as a result 
of bromination), the autoantibody binding changes accordingly (Fig. 37). 
The anti-DNA antibody binding dropped to 51 percent in low salt and 
34 percent in high salt against 80 percent when the polymer was in 
its native conformation. Native DNA brominated under low and high 
sodium chloride showed that polymers have undergone a conformational 
transition that deviates from native B-conformation. The Z- or Z-like 
epitopes on brominated polymer was detected by Z-DNA specific monoclonal 
(Z 22) and polyclonal (G 10) antibodies (Tal ' 15). The SLE anti-dsDNA 
i 
20 
'.O 
or bO 
80 
[109] 
k: - • - »•-
0 01 0.1 1.0 
COMPETITOR , Jig /ml 
10 20 
Fig.35. Inhibition of ant i -Z-DNA antibody (Z 22) binding to Z-DNA 
by poiy(dG-dC) (—-X-—), poly (dG-dC) bron-iinated in 0.15 M 
(—O—) and 4 M sodium chloride (—•—). 
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Fig.36. ' " ' I 'b i t .on oi z 22 antibody binding to Z-HNA by poiy(dA-dG) 
poly(dC-dT) ( - ^ ), poly(dA-dG).poly(dC-dT) brom.nat id in 0 i M 
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Fig.37. Inhibition of SLE anti-DNA IgG binding to native DNA by poly(dA-dG).poly(dC-dT) 
( " • " ) , poly(dA-dG).poly(dC-dT) brominated in 0.15 M (—)(•—) and ^ M sodium chloride 
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TABLE 15 
Inhibition of the Binding of Z22* and GIO* to Z-DNA and NBr^ 
Antigen on plate Inhibitor 
Maximum percent 
inhibition with 
Z22 GIO 
Z-DNA 
N &r'^• 
NBr^f 
N BrO. 
N Br'f 
NBrO. 
15 
15 
62 
12 
27 
22 
NT 
* Monoclonal mouse anti-Z-DNA antibody 
** Polyclonal goat anti-Z-DNA antibody 
NT = Not tested 
NBr^ & NBrO, 15 :Native DNA brominated under ^ M and 0.15 M sodium 
chloride respectively. 
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IgG showed dif ferent levels of binding with native DNA and its brominated 
analogues (Fig. 38). The binding of autoantibodies to bronninated DNA 
can be explained in two ways: First ly, the SLE antibodies are recognizing 
the remaining B-epitopes on brominated polymers (as not all the sequences 
in native DNA are capable of undergoing B — > Z transition) and secondly, 
they are exhibit ing polyspecif icity (a feature common to DNA autoanti-
bodies) and hence recognizing two di f ferent conformations. The SLE 
anti-dsDNA IgG binding to brominated DNA fragments have been presented 
in Table 16. Some of the brominated DNA fragments did not bind ant i -
DNA IgG at a l l . A possible explanation for such non-reactivi ty can be 
given if i t is assumed that such DNA fragments have undergone a radical 
conformational transit ion, which is possible in small DNA fragments. 
The DNA fragments rich in G + C content arc expected to undergo B — > Z 
transition more readily against DNA fragment of same length rich in 
A + T. Besides, the DNA molecule is a dynamic structure i t would be 
expected that this would alternate between these two states (namely 
B and Z) passing through many intermediate stages. 
[II*] 
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Fig.38. Inhibition of SLE anti-DNA IgG binding to native DNA by native DNA (• 
native DNA brominated in 0.15 M (-^-) and '^  M sodium chJoride (-0—). 
) and 
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TABLE 16 
Inhibition of the Binding of SLE Anti-DNA IgG to DNA Fragments 
of Varying Size Brominated Under Low and High Salt Conditions 
Maximum percent inhibition 
Inhibitor in low salt brominated in 
low salt high salt 
Native DNA fragments: 
(average size) 
300 bp 
175 bp 
120 bp 
90 bp 
70 bp 
70 
56 
51 
Ik 
66 
'^l 
26 
20 
NI 
NI 
Nl 
NI 
12 
36 
NI 
NI = No inhibit ion 
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Autoimmune diseases are a diverse group of conditions characterized 
by antibody recognition of normal components of the host. In many 
of these diseases, antibodies with self specificity or autoantibodies are 
important effectors. These antibodies mediate disease by a variety of 
distinct pathological mechanisms. Although anti-DNA antibodies were 
discovered more than twenty five years ago and despite the fact that 
numerous studies have suggested various aspects of autoimmune phenomena, 
spontaneous antibodies to nucleic acids remain puzzling in many aspects. 
Questions about the mechanisms leading to their formation, their specifi-
city, their relationship with antibodies directed towards other self consti-
tuentsis still unsolved (Harley and Scofield, 1991; Jacob et al., 1989; 
Cairns et al., 1989; Pisetsky et al., 1990; Brendel et al., 1991). 
Investigations designed to assess antibody specificity are important 
for many reasons. First they permit diagnostic tests to be developed 
to detect and monitor disease. activity (Hashizume e t al., 1987). Second, 
specificity studies will provide insight as to the nature of autoantigens 
that conceivably are required for eliciting spontaneously occurring anti-
DNA antibodies (Brigido and StoUar, 1991), Double stranded DNA (B-
conformation) is unlikely to be involved in SLE pathogenesis in view 
of its poor immunogenicity (Madaio et al., 198^; Pisetsky et al., 1990). 
Although commonly referred to as a discrete material, DNA displays 
a host of structural forms and sequence patterns that can serve as 
antigenic determinants (Stollar, 1975; Wells et al., 1980). The structural 
diversity and flexibility of DNA is inherent in its role in gene expression 
and providing recognition sites for regulatory molecules. A number of 
different conformations have been characterized by physiochemical and 
immunochemical methods (Lafer et al., 1986; Sanford et al., 1988), 
and structurally distinct regions probably exist along such DNA molecule. 
This microheterogeneity of structure provides for a multideterminant 
antigen. 
Antibodies reactive with cellular and nuclear components occur 
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spontaneously in SLE. The complex serology of SLE seems to indicate 
response to a large number of dif ferent autoantigens (Zouali et al . , 
1988). The binding diversity of lupus autoantibodies seems even greater 
when di f ferent nucleic acids and their modified preparations are used 
as test antigens (Ali et a l . , 1991; Alam and A l l , 1992; Aiam et d l . , 
1992; Ara et a l . , 1992; Ara and A l i , 1992). Because a mixed picture, 
with aspects of wide cross react iv i ty and aspects of select iv i ty, were 
observed in the preliminary studies, a more detailed analysis was performed 
to probe the basis for ant i -DNA antibody binding to DNA of varying 
size and conformation. 
The absorption rat io measurement (278/251) was found to be a 
quick assessment of IgG purify. IgG fractions having an absorbance ratio 
of less than 2.25 were further purif ied by exclusion chromatography 
on Sephadex G 200. Removal of proteins other than IgG was thought 
necessary in order to define the true binding specif icit ies of ant i -DNA 
IgG. 
Native DNA and DNA fragments of varying size prepared by 
controlled digestion wi th micrococcal nuclease were indeed double stranded 
as revealed by sharp melting prof i le. The T i dependence on fragment 
size was quite obvious. Moreover the samples were also digested v/ith 
single strand specific nuclease S 1 to get rid of single stranded regions 
in various DNA preparations. 
The immunological recognition of various DNA conformations 
by SLE ant i -DNA antibodies is of immense importance in relation to 
their polyspecif ici ty. Double stranded DNA has repetit ious antigenic 
determinant on the deoxyribose-phosphate backbone whereas most protein 
antigens have mult iple but di f ferent antigenic determinants. The binding 
specif ici ty of ant i-DNA antibodies with varying DNA conformations 
was analyzed by inhibition ELISA in which the abil i ty of a competitor 
to block the DNA-autoantibody interaction is assessed. The binding of 
SLE antibodies to native B-conformation, polymers di f fer ing from average 
B-helix geometry, DNA-RNA hybrid, Z-form of poly(dG-me dC) clearly 
demonstrated that native DNA is not always the preferred antigen for 
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antibodies in SLE and that both A- and Z-DNA shares immunogenic 
epitopes with native DNA. The aitered electrophoretic mobi l i ty in gel 
retardation assay of A- and B-conformation complexed wi th ant i-DNA 
antibodies reiterates the antibody binding to these conformers. The gel 
retardation assay (also known as band-shift assay) is a sensitive technique 
to detect DNA-protein interactions. Both A- and Z-DNA have been 
reported to be highly immunogenic in experimental animals (Nakazato, 
1980; Lafer et a l . , 1981) and the part icipation of these non-B conformations 
in the etiology of SLE cannot be ruled out. Double stranded regions 
of RNA (as in cruciform) and RNA-DNA hybrids adopt a right handed 
double helical form very similar to that of A-DNA and the occurrence 
of hybrid is closely linked with transcriptional act iv i ty of the cell (Busen 
et al . , 1982). Moreover, Z-conformation is a reversible structural form 
of DNA and its role in genetic act ivi t ies like transcription is well docu-
mented (Kmeic et al . , 1983; Peck and Wang, 1985). The existence of 
segments of lef t handed helices in native DNA has also been documented 
(Ueda et a l . , 1990; Wit t ig et a l . , 1991; 3imenez-Ruiz et a l . , 1991). 
Polyamines are known to bind negatively charged macromolecules 
such as nucleic acids. The binding of SLE ant i-DNA antibodies to DNA-
lysine photoadduct has further expanded the horizon of antibody poly-
specif ic i ty. DNA molecules di f fer ing from average B-helix geometry 
has been found to be immunogenic (Stellar, 1989) and DNA-lysine photo-
adduct has induced high t i ter antibodies (Islam, 1991). The ant i-DNA 
IgG purif ied through DNA-(polylysyl-Sepharose ifB) a f f in i ty column was 
homogeneous and found to be recognized equally well by native DNA 
and DNA-lysine photoconjugate. Moreover, the relat ive binding af f in i ty 
of ant i -DNA antibodies to DNA-lysine photoconjugate was appreciabl> 
higher than that with native DNA. By the photoaddition of one lysine 
molecule per helical turn of DNA, the native B-conformation was consider-
ably altered which has resulted in the generation of high a f f in i ty neo-
epitopes leaving much less epitope typical of B-conformation. The results 
conclusively suggest that a f f in i ty purif ied ant i -DNA IgG is indeed recogniz-
ing the altered conformation of DNA-lysine photoconjugate. The retention 
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of cross reactivity of affinity purified anti-DNA IgG with DNA-lysine 
photoadduct further strengthen the idea of an alternate antigen for the 
induction of antibodies cross reactive with native DNA. The DNA-lysine 
photoconjugate could be placed on the existing list of al ternate antigens 
for the induction of autoantibodies in SLE. Lysine rich histone H1 in 
nucleosomes thus on modification by physical, chemical or environmental 
agents might form DNA-histone adduct making it immunogenic and thus 
resulting in the production of autoantibodies cross reactive with nDNA. 
The findings of Mura and Stollar (198'f) have suggested the ability of 
different lysine-rich histones to cause varying conformational changes 
in native DNA molecules of interspersed repeatitive sequences. 
There has been considerable interest on the damaging effect ol 
reactive oxygen species (R05), like superoxide radical (O^) hydrogen 
peroxide and hydroxyl radical (Fridovich, 1986; Halliwell, 1987) on nucleic 
acids, proteins and lipids. These radicals modify DNA at various sites 
that includes base damage and cross linking between cytosine and tyrosine 
in nucleohistone (Dizdaroglu et al., 1991; Gajewski and Dizdaroglu, 1990). 
It has been shown that DNA after exposure to reactive oxygen species 
presents a more discriminating antigen than native DNA for the binding 
of SLE autoantibodies (Blount et al., 1989). Oxidative DNA damage 
resulting from active oxygen species has been hypothesized to play a 
critical role in several biological processes including aging, cancer and 
autoimmune diseases (Ames, 1983, 1989; Cerruti, 1985; Von Sonntag, 
1987). In our experimental conditions, the yield of free radical induced 
base modification predominantes over that of single strand breaks in 
DNA as revealed by decrease in UV absorbance at 260 nm. The decrease 
in Tm value by 6.5 °C with simultaneous decrease in total percent hyper-
chromicity of modified DNA is suggestive of the fact that DNA has 
been modified without undergoing major alterations in its secondary structure. 
In case of gross changes in the secondary structure of modified DNA 
the decrease in Tm value would have been much more than what has 
been observed. The alteration in the topological state of native DNA 
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has rendered it immunogenic as shown by experimentally induced high 
titer antibodies. The polyspecif icity exhibited by immune IgG was evident 
from inhibit ion ELISA results. Native DNA, RNA and synthetic poly-
nucleotides in B-conformations besides immunizing antigen were ef fect ive 
inhibitors. In an earlier study, native HNA on ul traviolet irradiation 
in presence of hydrogen peroxide induced antibodies which showed recogni-
tion for B-conformation (Ara et al . , 1992). The polyspecif icity exhibited 
by immune IgG was comparable to well established heterogeneity of 
murine and human SLE ant i -DNA antibodies. Naturally occurring ant i -
DNA antibodies of SLE patients showed enhanced binding wi th modified 
DNA and binding of ant i -DNA antibodies to native DNA was inhibited 
by modified DNA antigen. Since l i t t le is known about the stimulus that 
causes the production of ant i-DNA antibodies in SLE, the potential 
reactive oxygen mediated DNA damage may provide a new concept 
for the production of anti-nucleic acid antibodies in autoimmune disorders. 
The spontaneous production of ant i-DNA antibodies in SLE might arise 
as a consequence, of antigenic changes in UNA due to damage caused 
by hydroxyl radicals. The augmented levels of ROS in tissues is well 
related to many pathological conditions (Willson, 1979). Hydrogen peroxide 
on diffusion to a vulnerable part of the cell might generate hydroxyl 
radicals on reaction wi th ferrous ion, often bound to phosphates of DNA 
backbone and to various protein including those associated wi th chromatin 
which inturn could modify DNA (Floyd 1981, 1983). The iron promoters 
of hydroxyl radical formation exist _m vivo based on the observation 
that iron salts never exist " f ree" in biological system; they wi l l always 
be found to be associated with proteins, membranes, nucleic acids or 
low molecular weight chelating agents. 
The conformational and dynamical properties of DNA are strongly 
dependent upon both its sequence and microenvironment. It has been 
suggested that when a B-DNA segment is flanked by any di f ferent struc-
tural mot i fs (e.g. A, Z or B), there is an increase in overall f lex ib i l i ty 
provided by bending and enhanced f luctuations at the conformational 
interfaces (Reich et a l . , 1991). In 1972, when Pohl and 3ovin reported 
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right handed to left handed conformational transition for poIy(dG-dC) 
in high salt, it was presumed that DNA polymers rich in alternating 
punne-pyrimidine bases wi l l readily undergo B — > Z transit ion. Later, 
it was discovered that a str ict ly alternating purine-pyrimidine is neither 
necessary nor suff icient cr i ter ia for Z-DNA formation (McLean et al . , 
1986; Singleton et a l . , 1983; Ki lpatr ick et a l . , 198*^; Ellison et a l . , 1985). 
Nordheim et a l . , (1986) showed that stretches of poly(dG-dC) sequences 
do not contribute signif icantly to the presence of Z-DNA in f ixed polytene 
chromosomes of Drosophila melanogaster. Further studies showed that 
the potentially Z-DNA forming sequence d(GTGTACAC) adopts a right 
handed double helical conformation belonging to the A-DNA family (3ain 
et al . , 1987). In C.D. spectra the Z-form of poly(dG-dC) shows near 
inversion with a positive band at 26^ nm and a negative band at 29^ 
nm. Comparision of C.D. and UV result suggests that red shift in UV 
absorption is solely due to B — > Z transit ion. In 0.15 M and U M sodium 
chloride concentration the average of absorbance at 294 and 296 nm 
divided by absorbance at 260 nm, termed as absorbance rat io, was evaluated 
to monitor conformational transit ion in synthetic and native DNA polymers. 
For poly(dG-dC) in Z-conformation this value v^as computed to be 0.322. 
This reference value for prototype Z-DNA was used to monitor conforma-
tional transitions in native DNA, DNA fragments of varying size and 
poly(dA-dG).poly(dC-dT). Neither polymers resulted in absorbance ratio 
of 0.322 but data in Table 9 clearly indicates that in high salt this 
rat io IS changing which could occur as a result of conformational transit ion. 
The low and high salt conformations were stabilized by bromination 
(Moller et al . , 1984). The bromination had profound ef fect on the absor-
bance ratio of poly(dA-dG).poly(dC-dT), native DNA and DNA fragments. 
Native DNA brominated under low or high salt concentration, showed 
absorbance ratio greater than 0.3. Under identical conditions the absorbance 
ratio for DNA fragments of varying size varied between 0.2 to 0.38. 
This inturn shows that DNA fragments of varying size have dif ferent 
levels of potential i ty to undergo B- to Z- or Z-l ike conformations as 
the fragments wi l l have variation in the G+C and A+T content. Also 
native DNA or its fragments might undergo Z- or Z-l ike conformational 
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changes on bromination under low or high salt concentrations. The UV 
difference spectra of Z-form of brominated poly(dG-dC) had resennblance 
with native DNA or DNA fragments brominated under low or high sodium 
chloride concentrations. This further reiterates that both in native DNA 
and DNA fragments there are regions of interspersed sequences which 
has the potential to undergo B-to Z- or Z-l ike transitions upon bromination 
in high or low salt conditions. 
A variety of cations such as simple amines or polyamines that 
ef fect B- to Z-transit ion in poly(dG-me dC) are known to induce the 
collapse of native DNA into compact structural forms. These forms 
have been visualized by electron microscope as toroids, folded fiber, 
rods and spheroids (Gosule and Schellman, 1976, 1978; Chattoraj et al . , 
1978; Widom and Baldwin, 1980; Allison et a l . , 1981). The polyamines 
have been shown to stabilize DNA against thermial denaturation, alkaline 
denaturation, enzymatic degradation, shear induced strain and induce 
in vi t ro condensation of DNA (Vertino et a l . , 1987). The condensation 
of naked DNA takes place in a narrow range of polyamine concentration 
whereas the condensation of chromatin can occur in the presence of 
a wider range of polyamine concentration. The UV absorption spectra 
of D- and L-isomers of polylysine indicated their interact ion with DNA 
on charge basis. The effect of D-isomer was appreciably higher than 
L-isomer. At low concentrations of these isomers the absorbance at 
260 nm showed l i t t l e change but the ^ m i n was found to be red shifted 
to the extent of 2-k nm. The shift could be at t r ibuted to the presence 
of a ligand in DNA solution. The in( i-ase of absorbance around 300 
nm IS considered to be an indication of conformational transit ion in 
native B-conformation. The UV difference spectra clearly shows that 
at low concentrations of either D- or L-isomer, the primary interacting 
sites are phosphate groups on DNA backbone but once the charge neutral iza-
tion has been completed the B-conformation is on the verge of changing 
conformation wi th further increase in polylysine concentration. The most 
significant change in UV difference spectra was seen when poly-D-lysine 
concentration was raised to 25 ug/ml from 12.5 ug/ml . On comparision 
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the spectra showed the characterist ic of high salt brominated poly(dG-dC) 
which assumes 100 percent lef t handed Z-conformation. The data analysis 
of polylysine-DNA interaction suggests that in calf thymus DNA there 
are certain base pair sequences which are sensitive to changing polylysine 
level and can assume Z- or Z-l ike conformations. Since the eukaryotic 
DNA is heavily associated with proteins suff ic ient ly rich in lysine, such 
conformational transitions might serve as molecular signal for genetic 
events inside the cel l . Recently, Gunnia et a l . (1991) have shown that 
rabbits immunized wi th poly(dA-dC).poly(dG-dT) complexed wi th spermidine 
or spermine produced antibodies reacting wi th Z-DNA in addition to 
those binding toward poly(dA-dC).poly(dG-dT) and ssDNA. Antibodies 
el ici ted by polynucleotide - polyamine complexes had no react iv i ty tov/ards 
polyamines. This finding suggests that polyamines are capable of altering 
the immunogenicity of polynucleotides by mechanism involving the stabil iza-
tion of Z-DNA conformations. 
The conformational transit ion in native calf thymus DNA, poly(dA-dG). 
poly(dC-dT) and DNA fragments of varying size was evaluated by mono-
clonal ant i -Z-DNA antibody (Z22) and polyclonal goat antibody (GIO). 
Both Z22 and GIO are immunological probes for the detection of Z-
or analogous conformation. The binding of Z22 was nearly 80 percent 
inhibited at a Z-DNA concentration of 10 ug /m l . This demonstrate the 
high specif ici ty of Z22 for Z-conformation as poly(dG-dC) (B-form) or 
brominated under low salt showed no binding with Z22. Competit ion 
experiments with Z22 of poly(dA-dG).poly(dC-dT) brominated in 0.15 M 
or ^ M sodium chloride showed that potential i ty of this polymer to undergo 
Z-transit ion was l imi ted. Furthermore, competit ion ELISA with SLE ant i -
dsDNA IgG showed that poly(dA-dG).poly(dC-dT) has undergone conforma-
tional transit ion because binding of anti-dsDNA IgG to brominated polymers 
has declined signif icantly as compared to binding with native poly(dA-dG). 
poly(dC-dT). The Z- or Z-l ike epitopes on native DNA brominated under 
low and high sodium chloride concentrations was probed by both monoclonal 
(Z22) and polyclonal (GIO) ant i -Z-DNA antibodies. The binding of Z22 
and GIO was inhibited by both low and high salt brominated polymers. 
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This finding again reiterates that dispersed sequences of calf thymus 
DNA has potential to adopt Z- or Z-like confornriation. This means calf 
thymus DNA exhibits microheterogeneity whose conformation is dictated 
by its microenvironment. The binding of SLE ant i -DNA IgG to brominated 
native DNAs could be explained in two ways: 
I. In native DNA not all the epitopes typical of B-conformation 
has undergone conformational transit, MI and hence naturally occurring 
anti-dsDNA IgG is recognizing the remaining B-epitopes. 
I I . A population of SLE anti-dsDNA IgG is exhibit ing polyreact ivi ty 
wi th respect to varying DNA conformation and hence Z-l ike epitope 
could also interact with antibodies. 
To determine, whether reactive structure could be maintained 
in smaller fragments of native DNA the fragments of varying size after 
bromination in low and high salt were used as competitors of nDNA-
anti-DNA IgG interact ion. Unbrominated native DNA fragments were 
used as true competitors of SLE IgG to which inhibit ion values of low 
and high salt were compared. The data indicates that binding of ant i -
DNA IgG was signif icantly reduced when the polymer has undergone 
conformational transit ion. The level of transit ion seem to be affected 
by two factors: namely length of the DNA fragment and percentage 
of G-tC and A+T content. 
If ant i -DNA antibodies from human and murine SLE are capable 
of exhibiting polyspecif icity, the DNA molecule is a step ahead by its 
potential i ty to adopt mult iple conformations. The conformational f lex ib i l i ty 
of DNA depends on its microenvironment and any unusual structure 
which is stable at physiological conditions, suggest that such a structure 
might be formed ^H _vi_vo. The polyspecif icity phenomenon of naturally 
occurring ant i -DNA antibodies is most likely due to epitope that recur 
in di f ferent molecules, an economy of nature whose meaning awaits 
vigorous elucidation. 
Based on the results of present study, the fol lowing points of 
conclusion have been drawn: 
1. Native DNA and DNA fragments of varying size, brominated 
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under low and high sodium chloride concentrations is both structural ly 
and immunologically distinct from B-form DNA. That the bromination 
has induced neoepitopes capable of presenting Z- or Z-l ike features 
was detected by monoclonal (Z22) and polyclonal (GIO) ant i -Z-
DNA antibodies. 
2. In native calf thymus DNA there are dist inctive distribution of 
DNA sequence which has the potential to undergo B- to Z- or 
Z-l ike transitions upon binding with nucleoproteins rich in basic 
residues. 
3. The modified nucleic acid antigens may part icipate as antigenic 
stimulus for the production of a population of DNA cross reactive 
antibodies in SLE patients. The dietary, physical, chemical, or 
environmental agents might act, direct ly or indirect ly, as modif ier. 
^. The hydroxyl radical modified DNA may play an important role 
in the pathogenesis of SLE because of markedly decreased level 
of superoxide dismutase in active SLE patients; the excessively 
generated free radicals may exert its modifying ef fect on DNA 
and thus rendering i t immunogenic. 
3. The binding of A- or A- l ike conformation by SLE ant i -DNA antibodies 
suggest that such conformations may also act as potential auto-
immunogen for the induction of antibodies cross reactive wi th 
native DNA. 
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